{"schema":"hottub-news/story/v1","story":"st_mve5oebxpsurwqsjtw2q","title":"FDA flags rare vision-loss risk with GLP-1 drugs; doctors say patients need not panic","title_en":"FDA flags rare vision-loss risk with GLP-1 drugs; doctors say patients need not panic","outlets":185,"brief":{"text":"The FDA has mandated that safety labels for GLP-1 drugs include a warning about the potential risk of a rare eye condition known as NAION [1][3][4][5][6][9]. NAION, often referred to as an \"eye stroke,\" occurs when blood flow to the optic nerve is reduced [1][6]. The FDA issued this warning to ensure patients are aware of the potential risk, although the risk appears small and data is mixed [5][6]. The FDA's action follows reports and studies indicating a possible link between GLP-1 drugs and vision loss [2][3][4][5][6][7][8][10].","sources":["n_tbiseue6hwg33kiw7i2a","n_2r5tzqq2qks3sxp7vs6q","n_duzme2yo2yz54wzuhn2a","n_ovhpg4kfsvtjuxxiblpa","n_obwaxuyygw5l2ha643fa","n_kwzduzt5uphi6k4opl3q","n_qouyrewfu5lya2aanrfq","n_45qtcx4gdoevcliatywq","n_3ryjcjzggzeal5pvm4ja","n_lcbsug5fhqokts2egmhq"],"updated":"2026-11-10T17:15:06Z"},"page":"https://hottub.news/stories/stat-fda-warns-glp-1-drugs-carry-potential-risk-of-rare-eye-condition-mve5oebxps","count":200,"items":[{"id":"n_n6xh6sbjnfxfdh7zp3oa","seq":11389815,"kind":"article","title":"FDA Warns GLP-1 Drugs May Carry Rare Vision Loss Risk","url":"https://965kvki.com/ixp/33/p/fda-glp-1-naion-warning","published":"2026-11-15T20:00:00Z","seen":"2026-11-15T20:21:00Z","lang":"en","country":"US","source":{"id":"965kvki.com","name":"965kvki.com","domain":"965kvki.com","outlet":{"wikidata":"Q6340068","name":"KVKI-FM","type":"broadcaster","country":"US","designations":["radio station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Bruce Mikells"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"negative","tone":-0.30000001192092896,"political":0.14000000059604645},{"id":"n_cbjsqry5lmacntrwkcya","seq":11021170,"kind":"article","title":"減肥神藥恐釀永久失明! 美FDA要求所有GLP-1藥物全面加註警語 | 國際","url":"https://newtalk.tw/news/view/2026-11-14/1071156","published":"2026-11-14T08:19:00Z","seen":"2026-11-14T09:59:01Z","lang":"zh","country":"TW","source":{"id":"newtalk.tw","name":"newtalk.tw","domain":"newtalk.tw","outlet":{"wikidata":"Q11084535","name":"Newtalk News","type":"website","country":"TW","designations":["joint-stock company","news website"]}},"via":"gdelt-gkg-translingual","topics":["economy","science","crime","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6800000071525574,"sentiment":"negative","tone":-0.8899999856948853,"political":0.14000000059604645},{"id":"n_33cylopgnw5ayni4tytq","seq":10929623,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.kmbc.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-14T01:20:00Z","seen":"2026-11-14T01:20:00Z","lang":"en","country":"US","source":{"id":"kmbc.com","name":"kmbc.com","domain":"kmbc.com","outlet":{"wikidata":"Q6657537","name":"KMBC-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","science","health"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_litpi3kkjmt3yojgjjua","seq":10920385,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.wtae.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-14T00:37:01Z","seen":"2026-11-14T00:37:01Z","lang":"en","country":"US","source":{"id":"wtae.com","name":"wtae.com","domain":"wtae.com","outlet":{"wikidata":"Q7956049","name":"WTAE-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_nft5a2tn7c42dsrenxoa","seq":10920396,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.wgal.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-14T00:37:01Z","seen":"2026-11-14T00:37:01Z","lang":"en","country":"US","source":{"id":"wgal.com","name":"wgal.com","domain":"wgal.com","outlet":{"wikidata":"Q7949648","name":"WGAL","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_p2tteafcqcytvgx7t7xa","seq":10920638,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.wmtw.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-14T00:37:01Z","seen":"2026-11-14T00:37:01Z","lang":"en","country":"US","source":{"id":"wmtw.com","name":"wmtw.com","domain":"wmtw.com","outlet":{"wikidata":"Q7953108","name":"WMTW","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["science","economy","health"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q5572286","name":"glucagon-like peptide-1 agonist","type":"other"}],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_e3wvqylm7cgnuxzkyfgq","seq":10920841,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.ksbw.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-14T00:37:01Z","seen":"2026-11-14T00:37:01Z","lang":"en","country":"US","source":{"id":"ksbw.com","name":"ksbw.com","domain":"ksbw.com","outlet":{"wikidata":"Q6337510","name":"KSBW","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_dt2nxxswg5fb25y457eq","seq":10917977,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.wyff4.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-14T00:25:00Z","seen":"2026-11-14T00:25:00Z","lang":"en","source":{"id":"wyff4.com","name":"wyff4.com","domain":"wyff4.com"},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_x4mdkhqlnmgxombthwta","seq":10918553,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.koco.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-14T00:25:00Z","seen":"2026-11-14T00:25:00Z","lang":"en","country":"US","source":{"id":"koco.com","name":"koco.com","domain":"koco.com","outlet":{"wikidata":"Q6334811","name":"KOCO-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_adpfccd56t3zmxcb75xa","seq":10918881,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.mynbc5.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-14T00:25:00Z","seen":"2026-11-14T00:25:00Z","lang":"en","country":"US","source":{"id":"mynbc5.com","name":"mynbc5.com","domain":"mynbc5.com","outlet":{"wikidata":"Q3564770","name":"WPTZ","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","science","health"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_mkvbqgkgaetawqkh6shq","seq":10915559,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.gulfcoastnewsnow.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-14T00:05:01Z","seen":"2026-11-14T00:05:01Z","lang":"en","country":"US","source":{"id":"gulfcoastnewsnow.com","name":"gulfcoastnewsnow.com","domain":"gulfcoastnewsnow.com","outlet":{"wikidata":"Q7946994","name":"WBBH-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","science","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_mk3ijktkz5i5qf4ltquq","seq":10909855,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.wmur.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-13T23:43:21Z","seen":"2026-11-13T23:43:21Z","lang":"en","country":"US","source":{"id":"wmur.com","name":"wmur.com","domain":"wmur.com","outlet":{"wikidata":"Q7953134","name":"WMUR-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","science","health"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_uis6lcxmigr5npwmwhya","seq":10903896,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.wdsu.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-13T23:05:43Z","seen":"2026-11-13T23:05:43Z","lang":"en","country":"US","source":{"id":"wdsu.com","name":"wdsu.com","domain":"wdsu.com","outlet":{"wikidata":"Q7948586","name":"WDSU","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health","science"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_euztwafdjo5hjstzu4wa","seq":10899048,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.4029tv.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-13T22:54:00Z","seen":"2026-11-13T22:54:00Z","lang":"en","country":"US","source":{"id":"4029tv.com","name":"4029tv.com","domain":"4029tv.com","outlet":{"wikidata":"Q6330036","name":"KHBS","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health","science"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_ols7kb2jgqutkztoa72q","seq":10899191,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.wapt.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-13T22:54:00Z","seen":"2026-11-13T22:54:00Z","lang":"en","country":"US","source":{"id":"wapt.com","name":"wapt.com","domain":"wapt.com","outlet":{"wikidata":"Q14693413","name":"WAPT","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health","science"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_ngrkdlujbrxjsqpkvodq","seq":10909422,"kind":"article","title":"¿Usas medicamentos GLP-1? Esta es la advertencia sobre tu salud visual","url":"https://www.nvinoticias.com/oaxaca/salud/usas-medicamentos-glp-1-esta-es-la-advertencia-sobre-tu-salud-visual/196027","published":"2026-11-13T22:45:00Z","seen":"2026-11-13T23:40:00Z","lang":"es","source":{"id":"nvinoticias.com","name":"nvinoticias.com","domain":"nvinoticias.com"},"via":"gdelt-gkg-translingual","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.9399999976158142,"sentiment":"negative","tone":-0.5600000023841858,"political":0.05999999865889549},{"id":"n_tmvgbpxewo4a3cow3hgq","seq":10894134,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.kcra.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-13T22:30:00Z","seen":"2026-11-13T22:33:22Z","lang":"en","country":"US","source":{"id":"kcra.com","name":"kcra.com","domain":"kcra.com","outlet":{"wikidata":"Q6327252","name":"KCRA-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health","science"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_cyp7feqbsfocs4tt3ulq","seq":10894325,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.wlky.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-13T22:30:00Z","seen":"2026-11-13T22:33:22Z","lang":"en","country":"US","source":{"id":"wlky.com","name":"wlky.com","domain":"wlky.com","outlet":{"wikidata":"Q7952309","name":"WLKY","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","science","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_onnmfm3dorlsv6ycqrlq","seq":10892147,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.wbaltv.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-13T22:15:00Z","seen":"2026-11-13T22:29:55Z","lang":"en","country":"US","source":{"id":"wbaltv.com","name":"wbaltv.com","domain":"wbaltv.com","outlet":{"wikidata":"Q7946968","name":"WBAL-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["health","economy","science"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_eriuvz54j7vhhq6iiiuq","seq":10878109,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.wlwt.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-13T21:45:00Z","seen":"2026-11-13T21:45:59Z","lang":"en","country":"US","source":{"id":"wlwt.com","name":"wlwt.com","domain":"wlwt.com","outlet":{"wikidata":"Q7952573","name":"WLWT","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health","science"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_el2c7ekb7kczg2g6eqxa","seq":10876477,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.ketv.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-13T21:30:00Z","seen":"2026-11-13T21:43:14Z","lang":"en","country":"US","source":{"id":"ketv.com","name":"ketv.com","domain":"ketv.com","outlet":{"wikidata":"Q3191361","name":"KETV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health","science"],"mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_unvhq2c3dtpnvo6poo5a","seq":10875048,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.koat.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-13T21:15:00Z","seen":"2026-11-13T21:40:18Z","lang":"en","country":"US","source":{"id":"koat.com","name":"koat.com","domain":"koat.com","outlet":{"wikidata":"Q14706024","name":"KOAT-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health","science"],"mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_nwgnanp2mq7ilh42ttpa","seq":10875830,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.wvtm13.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-13T21:15:00Z","seen":"2026-11-13T21:40:18Z","lang":"en","country":"US","source":{"id":"wvtm13.com","name":"wvtm13.com","domain":"wvtm13.com","outlet":{"wikidata":"Q7957034","name":"WVTM-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health","science"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_hxawmwioqbtdsfwjt6dq","seq":10876136,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.kcci.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-13T21:15:00Z","seen":"2026-11-13T21:40:18Z","lang":"en","country":"US","source":{"id":"kcci.com","name":"kcci.com","domain":"kcci.com","outlet":{"wikidata":"Q6326610","name":"KCCI","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health","science"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_j3lhyq7pvtqokkftmu6a","seq":10860433,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.wisn.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-13T20:55:46Z","seen":"2026-11-13T20:55:46Z","lang":"en","country":"US","source":{"id":"wisn.com","name":"wisn.com","domain":"wisn.com","outlet":{"wikidata":"Q3564700","name":"WISN-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","science","health"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7799999713897705,"political":0.17000000178813934},{"id":"n_rqidrfvtkae4x65sceta","seq":10880328,"kind":"article","title":"FDA’s new warning about GLP-1s and blindness explained","url":"https://www.wesh.com/article/fdas-warning-glp-1s-blindness/74426101","summary":"“The FDA is making this warning out of an abundance of caution\" | Doctors still aren’t sure how these drugs could have this effect on the body.","published":"2026-11-13T20:16:00Z","seen":"2026-11-13T21:53:07Z","lang":"en","country":"US","source":{"id":"kite-wesh-com-87f747","name":"wesh.com","domain":"wesh.com","outlet":{"wikidata":"Q7949047","name":"WESH","type":"broadcaster","country":"US","designations":["television station"]}},"via":"kite-wesh-com-87f747","topics":["florida"],"image":"https://kubrick.htvapps.com/htv-prod/images/34e92733-3e5f-44aa-9615-9a763d2543f6.jpg","mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.699999988079071,"political":0.17000000178813934},{"id":"n_c2wohasvrgrrxjoyroua","seq":10883993,"kind":"article","title":"FDA’s new warning about GLP-1s and blindness explained","url":"https://www.wpbf.com/article/fdas-warning-glp-1s-blindness/74426101","summary":"“The FDA is making this warning out of an abundance of caution\" | Doctors still aren’t sure how these drugs could have this effect on the body.","published":"2026-11-13T20:16:00Z","seen":"2026-11-13T22:06:38Z","lang":"en","country":"US","source":{"id":"kite-wpbf-com-14eb4d","name":"wpbf.com","domain":"wpbf.com","outlet":{"wikidata":"Q7954168","name":"WPBF","type":"broadcaster","country":"US","designations":["television station"]}},"via":"kite-wpbf-com-14eb4d","topics":["florida"],"image":"https://kubrick.htvapps.com/htv-prod/images/34e92733-3e5f-44aa-9615-9a763d2543f6.jpg","mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.699999988079071,"political":0.17000000178813934},{"id":"n_pkxrpe5n7qriurvekqhq","seq":10884987,"kind":"article","title":"FDA’s new warning about GLP-1s and blindness explained","url":"https://www.wcvb.com/article/fdas-warning-glp-1s-blindness/74426101","summary":"“The FDA is making this warning out of an abundance of caution\" | Doctors still aren’t sure how these drugs could have this effect on the body.","published":"2026-11-13T20:16:00Z","seen":"2026-11-13T22:09:07Z","lang":"en","country":"US","source":{"id":"kite-wcvb-com-6be115","name":"wcvb.com","domain":"wcvb.com","outlet":{"wikidata":"Q7948158","name":"WCVB-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"kite-wcvb-com-6be115","topics":["boston"],"image":"https://kubrick.htvapps.com/htv-prod/images/34e92733-3e5f-44aa-9615-9a763d2543f6.jpg","mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.699999988079071,"political":0.17000000178813934},{"id":"n_lwzbne3lglmd5az7g7ua","seq":10885705,"kind":"article","title":"FDA’s new warning about GLP-1s and blindness explained","url":"https://www.wxii12.com/article/fdas-warning-glp-1s-blindness/74426101","summary":"“The FDA is making this warning out of an abundance of caution\" | Doctors still aren’t sure how these drugs could have this effect on the body.","published":"2026-11-13T20:16:00Z","seen":"2026-11-13T22:12:28Z","lang":"en","country":"US","source":{"id":"kite-wxii12-com-fded67","name":"wxii12.com","domain":"wxii12.com","outlet":{"wikidata":"Q7957644","name":"WXII-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"kite-wxii12-com-fded67","image":"https://kubrick.htvapps.com/htv-prod/images/34e92733-3e5f-44aa-9615-9a763d2543f6.jpg","mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.699999988079071,"political":0.17000000178813934},{"id":"n_ws7h63avjrqfn3zza6wq","seq":10811214,"kind":"article","title":"FDA avertizează asupra riscului ocular al GLP-1","url":"https://www.sfin.ro/avertisment-fda-medicamente-glp-1","published":"2026-11-13T15:09:00Z","seen":"2026-11-13T18:29:20Z","lang":"ro","country":"RO","source":{"id":"sfin.ro","name":"sfin.ro","domain":"sfin.ro"},"via":"gdelt-gkg-translingual","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7400000095367432,"sentiment":"negative","tone":-0.6700000166893005,"political":0.09000000357627869},{"id":"n_2zjoivl776h6jvrf6ffa","seq":10807410,"kind":"article","title":"Rare Eye Condition Prompts New FDA Warning on Popular GLP-1 Drugs","url":"https://www.neurologyadvisor.com/news/rare-eye-condition-prompts-new-fda-warning-on-popular-glp-1-drugs","published":"2026-11-13T14:41:00Z","seen":"2026-11-13T18:19:01Z","lang":"en","source":{"id":"neurologyadvisor.com","name":"neurologyadvisor.com","domain":"neurologyadvisor.com"},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8399999737739563,"sentiment":"negative","tone":-0.75,"political":0.05999999865889549},{"id":"n_i5y53nqzwhagtka2ydxa","seq":10639633,"kind":"article","title":"FDA adds rare vision-loss warning to popular GLP-1 drugs","url":"https://www.suncommercial.com/gcdailyworld/gcdailyworld/article_dcad91cb-4c2c-5548-9882-30da2cc26697.html","published":"2026-11-13T06:00:00Z","seen":"2026-11-13T10:02:11Z","lang":"en","country":"US","source":{"id":"suncommercial.com","name":"suncommercial.com","domain":"suncommercial.com","outlet":{"wikidata":"Q55666785","name":"Vincennes Sun-Commercial","type":"newspaper","country":"US","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7900000214576721,"sentiment":"negative","tone":-0.7400000095367432,"political":0.07000000029802322},{"id":"n_7bglx4by3sb2k35hw4qq","seq":10543707,"kind":"article","title":"FDA warns GLP-1 users of rare eye stroke risk as lawsuits emerge","url":"https://www.kfvs12.com/2026/11/12/fda-warns-glp-1-users-rare-eye-stroke-risk-lawsuits-emerge","published":"2026-11-13T03:36:17Z","seen":"2026-11-13T03:36:17Z","lang":"en","country":"US","source":{"id":"kfvs12.com","name":"kfvs12.com","domain":"kfvs12.com","outlet":{"wikidata":"Q14704356","name":"KFVS-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health","education"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6100000143051147,"sentiment":"negative","tone":-0.9100000262260437,"political":0.28999999165534973},{"id":"n_5evv4n2q36lsjs2aiz3a","seq":10511378,"kind":"article","title":"美FDA要求GLP-1減重藥加註失明風險警語","url":"https://n.yam.com/Article/20261113214203","published":"2026-11-12T23:31:00Z","seen":"2026-11-13T00:54:00Z","lang":"zh","source":{"id":"yam.com","name":"yam.com","domain":"yam.com","outlet":{"wikidata":"Q15912872","name":"Yam","type":"other","designations":["business"]}},"via":"gdelt-gkg-translingual","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6399999856948853,"sentiment":"negative","tone":-0.7099999785423279,"political":0.1599999964237213},{"id":"n_qsuhcxvi2bkzdmthfgdq","seq":10492251,"kind":"article","title":"FDA warns GLP-1 users of rare eye stroke risk as lawsuits emerge","url":"https://www.cleveland19.com/2026/11/12/fda-warns-glp-1-users-rare-eye-stroke-risk-lawsuits-emerge","published":"2026-11-12T23:15:00Z","seen":"2026-11-12T23:27:44Z","lang":"en","country":"US","source":{"id":"cleveland19.com","name":"cleveland19.com","domain":"cleveland19.com","outlet":{"wikidata":"Q7953839","name":"WOIO","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["education","economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6100000143051147,"sentiment":"negative","tone":-0.9100000262260437,"political":0.28999999165534973},{"id":"n_vfsbtc373ssos53awekq","seq":10476322,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained – PolitiFact","url":"https://politifact.com/article/2026/nov/12/fda-glp1-warning-blindness-vision-loss-naion","published":"2026-11-12T21:30:00Z","seen":"2026-11-12T22:36:24Z","lang":"en","country":"US","source":{"id":"politifact.com","name":"politifact.com","domain":"politifact.com","outlet":{"wikidata":"Q3394318","name":"PolitiFact","type":"website","country":"US","designations":["fact-checking organisation","organization","website"]}},"via":"gdelt-gkg-english","topics":["economy","science","health"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q3394318","name":"PolitiFact","type":"org"}],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6899999976158142,"sentiment":"negative","tone":-0.7599999904632568,"political":0.49000000953674316},{"id":"n_zp6blsbkftajqb2timra","seq":10372382,"kind":"article","title":"FDA flags vision loss risk on GLP-1 weight loss drugs","url":"http://www.britainnews.net/news/279424298/fda-flags-vision-loss-risk-on-glp-1-weight-loss-drugs","published":"2026-11-12T16:30:00Z","seen":"2026-11-12T17:26:33Z","lang":"en","source":{"id":"britainnews.net","name":"britainnews.net","domain":"britainnews.net"},"via":"gdelt-gkg-english","topics":["health","economy"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.800000011920929,"sentiment":"negative","tone":-0.4399999976158142,"political":0.11999999731779099},{"id":"n_vg62sxucidityszl64sq","seq":10350438,"kind":"article","title":"FDA flags vision loss risk on GLP-1 weight loss drugs","url":"http://www.azerbaijannews.net/news/279424298/fda-flags-vision-loss-risk-on-glp-1-weight-loss-drugs","published":"2026-11-12T16:00:00Z","seen":"2026-11-12T16:30:52Z","lang":"en","source":{"id":"azerbaijannews.net","name":"azerbaijannews.net","domain":"azerbaijannews.net"},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.800000011920929,"sentiment":"negative","tone":-0.4399999976158142,"political":0.11999999731779099},{"id":"n_a7uatyb7v7ta5zdfvfca","seq":10350615,"kind":"article","title":"FDA flags vision loss risk on GLP-1 weight loss drugs","url":"http://www.myanmarnews.net/news/279424298/fda-flags-vision-loss-risk-on-glp-1-weight-loss-drugs","published":"2026-11-12T16:00:00Z","seen":"2026-11-12T16:30:52Z","lang":"en","source":{"id":"myanmarnews.net","name":"myanmarnews.net","domain":"myanmarnews.net"},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.800000011920929,"sentiment":"negative","tone":-0.4399999976158142,"political":0.11999999731779099},{"id":"n_iwjgouguv5skx7ha225q","seq":10351191,"kind":"article","title":"FDA flags vision loss risk on GLP-1 weight loss drugs","url":"http://www.australiannews.net/news/279424298/fda-flags-vision-loss-risk-on-glp-1-weight-loss-drugs","published":"2026-11-12T16:00:00Z","seen":"2026-11-12T16:30:52Z","lang":"en","source":{"id":"australiannews.net","name":"australiannews.net","domain":"australiannews.net"},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.800000011920929,"sentiment":"negative","tone":-0.4399999976158142,"political":0.11999999731779099},{"id":"n_6vlnpl3a5ifqaeb7kqlq","seq":10361076,"kind":"article","title":"GLP-1 kilo verme ilaçlarında körlük riski uyarısı","url":"https://www.timeturk.com/kilo-verme-ilaclarinda-korluk-riski-uyarisi","published":"2026-11-12T15:30:00Z","seen":"2026-11-12T16:53:58Z","lang":"tr","source":{"id":"timeturk.com","name":"timeturk.com","domain":"timeturk.com"},"via":"gdelt-gkg-translingual","topics":["economy","health"],"authors":["Cumali Dalk&#x131","l&#x131","&#xE7"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8600000143051147,"sentiment":"negative","tone":-0.8199999928474426,"political":0.05000000074505806},{"id":"n_6pckdfsvxfjkmy7xqfrq","seq":10439653,"kind":"article","title":"GLP-1 Drugs and Vision Loss: What the FDA Warning Means","url":"https://www.menshealth.com/health/a74411778/glp-1-fda-eye-warning","published":"2026-11-12T15:06:00Z","seen":"2026-11-12T20:50:35Z","lang":"en","source":{"id":"menshealth.com","name":"menshealth.com","domain":"menshealth.com","outlet":{"wikidata":"Q384671","name":"Men's Health","type":"magazine","designations":["magazine","website"]}},"via":"gdelt-gkg-english","topics":["economy","health","education"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8100000023841858,"sentiment":"negative","tone":-0.800000011920929,"political":0.17000000178813934},{"id":"n_mtyuht22p3gfgzoa3svq","seq":10344735,"kind":"article","title":"FDA flags vision loss risk on GLP-1 weight loss drugs","url":"http://www.thailandnews.net/news/279424298/fda-flags-vision-loss-risk-on-glp-1-weight-loss-drugs","published":"2026-11-12T15:00:00Z","seen":"2026-11-12T16:17:47Z","lang":"en","source":{"id":"thailandnews.net","name":"thailandnews.net","domain":"thailandnews.net"},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.800000011920929,"sentiment":"negative","tone":-0.4399999976158142,"political":0.11999999731779099},{"id":"n_p37roroa2ol7jan5f5bq","seq":10318571,"kind":"article","title":"FDA flags vision loss risk on GLP-1 weight loss drugs","url":"http://www.bruneinews.net/news/279424298/fda-flags-vision-loss-risk-on-glp-1-weight-loss-drugs","published":"2026-11-12T14:30:00Z","seen":"2026-11-12T14:59:56Z","lang":"en","source":{"id":"bruneinews.net","name":"bruneinews.net","domain":"bruneinews.net"},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.800000011920929,"sentiment":"negative","tone":-0.4399999976158142,"political":0.11999999731779099},{"id":"n_raqxusiozmy7mks6fkoa","seq":10317042,"kind":"article","title":"FDA flags vision loss risk on GLP-1 weight loss drugs","url":"http://www.calcuttanews.net/news/279424298/fda-flags-vision-loss-risk-on-glp-1-weight-loss-drugs","published":"2026-11-12T14:15:00Z","seen":"2026-11-12T14:56:40Z","lang":"en","source":{"id":"calcuttanews.net","name":"calcuttanews.net","domain":"calcuttanews.net"},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.800000011920929,"sentiment":"negative","tone":-0.4399999976158142,"political":0.11999999731779099},{"id":"n_vokujwmqywjf6ukjl34a","seq":10317396,"kind":"article","title":"FDA flags vision loss risk on GLP-1 weight loss drugs","url":"http://www.shanghainews.net/news/279424298/fda-flags-vision-loss-risk-on-glp-1-weight-loss-drugs","published":"2026-11-12T14:15:00Z","seen":"2026-11-12T14:56:40Z","lang":"en","source":{"id":"shanghainews.net","name":"shanghainews.net","domain":"shanghainews.net"},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.800000011920929,"sentiment":"negative","tone":-0.4399999976158142,"political":0.11999999731779099},{"id":"n_oqzeelsumpxp2bhtjlfq","seq":10347285,"kind":"article","title":"FDA Orders New Blindness Warning for Popular GLP-1 Weight Loss Drugs","url":"https://foxbaltimore.com/fox45-mornings/fda-orders-new-blindness-warning-for-popular-glp-1-weight-loss-drugs","published":"2026-11-12T13:56:00Z","seen":"2026-11-12T16:24:05Z","lang":"en","country":"US","source":{"id":"foxbaltimore.com","name":"foxbaltimore.com","domain":"foxbaltimore.com","outlet":{"wikidata":"Q7947106","name":"WBFF","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7400000095367432,"sentiment":"negative","tone":-0.8399999737739563,"political":0.07999999821186066},{"id":"n_235jhznmms7qvnpqfmfa","seq":10291724,"kind":"article","title":"Предупреждение за риск за зрението от GLP-1 изиска FDA","title_en":"Warning about vision risk from GLP-1 issued by FDA","url":"https://www.puls.bg/aktsenti-c-16/preduprezhdenie-za-risk-za-zrenieto-ot-glp-1-iziska-fda-n-59227","summary":"Независимо от ползите на GLP-1 за лечение на диабет и отслабване те не са безусловно безопасни и следва да се обръща внимание на продупрежденията","published":"2026-11-12T13:52:40Z","seen":"2026-11-12T13:52:40Z","lang":"bg","country":"BG","source":{"id":"kite-puls-bg-f1e4b3","name":"puls.bg","domain":"puls.bg"},"via":"kite-puls-bg-f1e4b3","entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"image":"https://www.puls.bg/cache/9/c/b/9/d/9cb9d48657f199f2ef132ec3691c0b0bd1a1b9fa.jpeg","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7099999785423279,"sentiment":"negative","tone":-0.6100000143051147,"political":0.23999999463558197},{"id":"n_nksm46oc347shcogkzyq","seq":10314042,"kind":"article","title":"FDA flags vision loss risk on GLP-1 weight loss drugs","url":"http://www.laosnews.net/news/279424298/fda-flags-vision-loss-risk-on-glp-1-weight-loss-drugs","published":"2026-11-12T13:45:00Z","seen":"2026-11-12T14:50:45Z","lang":"en","source":{"id":"laosnews.net","name":"laosnews.net","domain":"laosnews.net"},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.800000011920929,"sentiment":"negative","tone":-0.4399999976158142,"political":0.11999999731779099},{"id":"n_wyufa7ng67ojswwbn3oa","seq":10314968,"kind":"article","title":"FDA flags vision loss risk on GLP-1 weight loss drugs","url":"http://www.afghanistannews.net/news/279424298/fda-flags-vision-loss-risk-on-glp-1-weight-loss-drugs","published":"2026-11-12T13:45:00Z","seen":"2026-11-12T14:50:45Z","lang":"en","source":{"id":"afghanistannews.net","name":"afghanistannews.net","domain":"afghanistannews.net"},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.800000011920929,"sentiment":"negative","tone":-0.4399999976158142,"political":0.11999999731779099},{"id":"n_nkfunjycittqpx7xnhca","seq":10314205,"kind":"article","title":"Could Your GLP-1s Make You Blind? Here's What to Make of the FDA's Latest Notice.","url":"https://www.womenshealthmag.com/health/a74401701/glp-1-fda-eye-warning","published":"2026-11-12T12:00:00Z","seen":"2026-11-12T14:50:45Z","lang":"en","source":{"id":"womenshealthmag.com","name":"womenshealthmag.com","domain":"womenshealthmag.com","outlet":{"wikidata":"Q8030918","name":"Women's Health","type":"magazine","designations":["lifestyle magazine","magazine","website","women's magazine"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.699999988079071,"sentiment":"negative","tone":-0.7599999904632568,"political":0.14000000059604645},{"id":"n_i3p4q74rzd4gw6rsv2ja","seq":10292736,"kind":"article","title":"Obrigatório o aviso sobre risco de perda de visão em medicamentos GLP-1 nos EUA","url":"https://www.diariocoimbra.pt/2026/11/12/obrigatorio-o-aviso-sobre-risco-de-perda-de-visao-em-medicamentos-glp-1-nos-eua","published":"2026-11-12T11:45:00Z","seen":"2026-11-12T13:37:04Z","lang":"pt","country":"PT","source":{"id":"diariocoimbra.pt","name":"diariocoimbra.pt","domain":"diariocoimbra.pt","outlet":{"wikidata":"Q5285150","name":"Diário de Coimbra","type":"newspaper","designations":["newspaper"]}},"via":"gdelt-gkg-translingual","topics":["health","economy"],"authors":["rutemelo"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"neutral","tone":-0.7099999785423279,"political":0.11999999731779099},{"id":"n_vb7woc3tyid3ve5u7xxa","seq":10262932,"kind":"article","title":"US FDA flags blindness risk from GLP-1 drugs: What patients should know","url":"https://www.business-standard.com/health/us-fda-flags-blindness-risk-from-glp-1-drugs-what-patients-should-know-126111200915_1.html","published":"2026-11-12T10:45:00Z","seen":"2026-11-12T12:16:22Z","lang":"en","country":"IN","source":{"id":"business-standard.com","name":"business-standard.com","domain":"business-standard.com","outlet":{"wikidata":"Q2307816","name":"Business Standard","type":"newspaper","country":"IN","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","business","crime","health"],"authors":["Business Standard"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.9200000166893005,"sentiment":"negative","tone":-0.8399999737739563,"political":0.10000000149011612},{"id":"n_v2ua73y23gejt3il7rpa","seq":10312575,"kind":"article","title":"FDA Adds Vision Loss Warning to GLP-1s","url":"https://radio.foxnews.com/2026/11/12/fda-adds-vision-loss-warning-to-glp-1s","published":"2026-11-12T09:08:00Z","seen":"2026-11-12T14:45:37Z","lang":"en","country":"US","source":{"id":"foxnews.com","name":"foxnews.com","domain":"foxnews.com","outlet":{"wikidata":"Q186068","name":"Fox News","type":"other","country":"US","designations":["cable news in the united states","specialty channel"]}},"via":"gdelt-gkg-english","topics":["economy"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6000000238418579,"sentiment":"negative","tone":-0.7400000095367432,"political":0.09000000357627869},{"id":"n_gl4uafw7gk57bd4o4dra","seq":10237930,"kind":"article","title":"GLP-1 ilaçların olası göz riski FDA uyarısıyla yeniden gündeme geldi","url":"https://www.haberler.com/saglik/glp-1-ilaclarin-olasi-goz-riski-fda-uyarisiyla-20420029-haberi","published":"2026-11-12T08:56:00Z","seen":"2026-11-12T10:50:48Z","lang":"tr","source":{"id":"haberler.com","name":"haberler.com","domain":"haberler.com"},"via":"gdelt-gkg-translingual","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7900000214576721,"sentiment":"neutral","tone":-0.7200000286102295,"political":0.12999999523162842},{"id":"n_hojs47bjevc2mnge37ga","seq":10204653,"kind":"article","title":"La FDA alerta sobre un posible riesgo de desarrollar neuropatía óptica isquémica asociado a los medicamentos GLP-1","url":"https://www.diariodesevilla.es/salud/fda-alerta-posible-riesgo-desarrollar-neuropatia-optica-isquemica-medicamentos-glp-1_0_2008473662.html","published":"2026-11-12T06:01:00Z","seen":"2026-11-12T09:08:36Z","lang":"es","country":"ES","source":{"id":"diariodesevilla.es","name":"diariodesevilla.es","domain":"diariodesevilla.es","outlet":{"wikidata":"Q3026338","name":"Diario de Sevilla","type":"newspaper","country":"ES","designations":["daily newspaper"]}},"via":"gdelt-gkg-translingual","topics":["health","economy"],"authors":["Freepik"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8100000023841858,"sentiment":"negative","tone":-0.75,"political":0.05999999865889549},{"id":"n_quh254ievkf5choxkkrq","seq":10137812,"kind":"article","title":"GLP-1减肥药被警示或升高罕见严重眼部疾病风险，患者是否需要恐慌","url":"https://www.yicai.com/news/103437719.html","published":"2026-11-12T04:15:00Z","seen":"2026-11-12T05:09:00Z","lang":"zh","country":"CN","source":{"id":"yicai.com","name":"yicai.com","domain":"yicai.com","outlet":{"wikidata":"Q15925681","name":"China Business News","type":"newspaper","country":"CN","designations":["newspaper"]}},"via":"gdelt-gkg-translingual","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.9200000166893005,"sentiment":"negative","tone":-0.7900000214576721,"political":0.07000000029802322},{"id":"n_wpwx5uodnpqcyrgcry6q","seq":10390560,"kind":"article","title":"FDA Orders New Warning on GLP-1 Drugs Over Rare Blindness Risk","url":"https://www.aol.com/articles/fda-orders-warning-glp-1-204057000.html","published":"2026-11-11T20:40:00Z","seen":"2026-11-12T18:10:48Z","lang":"en","country":"US","source":{"id":"aol.com","name":"aol.com","domain":"aol.com","outlet":{"wikidata":"Q27585","name":"AOL","type":"website","country":"US","designations":["business","company","enterprise","media company","online service provider","search engine","web portal"]}},"via":"gdelt-gkg-english","topics":["economy","health","education"],"authors":["AOL"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6600000262260437,"sentiment":"negative","tone":-0.5899999737739563,"political":0.15000000596046448},{"id":"n_fpcfzg5bzhduchzbyaua","seq":9994786,"kind":"article","title":"《TAIPEI TIMES》 GLP-1 weight-loss drugs can cause blindness in rare cases, FDA warns","title_en":"FDA warns that GLP-1 weight-loss drugs can cause blindness in rare cases.","url":"https://news.ltn.com.tw/news/focus/breakingnews/5637650","summary":"By Jonathan Chin / Staff writer, with CNA Taiwan is weighing its first-ever compensation claim ov...…","published":"2026-11-11T19:00:00Z","seen":"2026-11-11T19:38:59Z","lang":"zh","country":"TW","source":{"id":"kite-news-ltn-com-tw-3ff025","name":"news.ltn.com.tw","domain":"news.ltn.com.tw"},"via":"kite-news-ltn-com-tw-3ff025","entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6899999976158142,"sentiment":"negative","tone":-0.6700000166893005,"political":0.20000000298023224},{"id":"n_mnizrscdsbudc67hmjqa","seq":9948849,"kind":"article","title":"GLP-1 weight-loss drugs can cause blindness in rare cases, FDA warns","url":"https://www.taipeitimes.com/News/front/archives/2026/11/12/2003867590","published":"2026-11-11T17:00:00Z","seen":"2026-11-11T17:25:18Z","lang":"en","country":"TW","source":{"id":"taipeitimes.com","name":"taipeitimes.com","domain":"taipeitimes.com","outlet":{"wikidata":"Q714427","name":"Taipei Times","type":"newspaper","country":"TW","designations":["newspaper","online newspaper","periodical"]}},"via":"gdelt-gkg-english","topics":["economy","health","politics"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.7099999785423279,"political":0.07000000029802322},{"id":"n_czk6phh2kzb2j3mzfwgq","seq":9988563,"kind":"article","title":"FDAがGLP-1製剤の「非動脈炎性前部虚血性視神経症」リスク追記を要請","url":"https://medical.nikkeibp.co.jp/leaf/mem/pub/hotnews/int/202611/595230.html","summary":"米食品医薬品局（FDA）は2026年11月9日、GLP-1受容体作動薬（GIP/GLP-1受容体作動薬を含む）使用患者に非動脈炎性前部虚血性視神経症（NAION）の潜在的リスクがあるとして、添付文書に情報を追記するよう製薬企業に求めた。 NAIONは片眼性の急性かつ無痛の視力低下を引き起こすまれな疾患で、リスク因子として喫煙、糖尿病、高血圧、睡眠時無呼吸、貧血、腎臓病などが挙げられている。GLP-1製剤との関連については、2024年の研究報告（Hathaway JT, et al. JAMA Ophthalmol. 2024;142:732-9.）を受け、FDAがさらなる検討を行った","published":"2026-11-11T15:00:00Z","seen":"2026-11-11T19:14:25Z","lang":"ja","source":{"id":"kite-medical-nikkeibp-co-jp-e251a7","name":"medical.nikkeibp.co.jp","domain":"medical.nikkeibp.co.jp"},"via":"kite-medical-nikkeibp-co-jp-e251a7","topics":["medicine"],"authors":["日経メディカル Online"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7599999904632568,"sentiment":"neutral","tone":-0.3700000047683716,"political":0.10999999940395355},{"id":"n_x74xngavv3c6d24hwrfq","seq":9944174,"kind":"article","title":"Rare Eye Condition Prompts New FDA Warning On Popular GLP-1 Drugs","url":"https://www.renalandurologynews.com/news/rare-eye-condition-prompts-new-fda-warning-on-popular-glp-1-drugs","published":"2026-11-11T14:14:00Z","seen":"2026-11-11T17:11:54Z","lang":"en","source":{"id":"renalandurologynews.com","name":"renalandurologynews.com","domain":"renalandurologynews.com"},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8399999737739563,"sentiment":"negative","tone":-0.75,"political":0.05999999865889549},{"id":"n_v77l3jsbq6ma2xwr2ixa","seq":9888579,"kind":"article","title":"FDA flags rare vision-loss risk with GLP-1 drugs; doctors say patients need not panic","url":"https://www.thehindubusinessline.com/news/fda-flags-rare-vision-loss-risk-with-glp-1-drugs-doctors-say-patients-need-not-panic/article71690072.ece","summary":"Indian endocrinologists, however, say the risk appears small and patients should not panic, while stressing on eye examinations if symptoms develop","published":"2026-11-11T14:13:27Z","seen":"2026-11-11T14:38:58Z","lang":"en","country":"IN","source":{"id":"kite-thehindubusinessline-com-b0e07f","name":"thehindubusinessline.com","domain":"thehindubusinessline.com","outlet":{"wikidata":"Q279739","name":"Business Line","type":"newspaper","country":"IN","designations":["newspaper"]}},"via":"kite-thehindubusinessline-com-b0e07f","topics":["news"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"image":"https://bl-i.thgim.com/public/incoming/gkt5r0/article71690231.ece/alternates/LANDSCAPE_1200/IMG_iStock-2238129175_2_1_7KFR1MO5.jpg","mentions":3,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8799999952316284,"sentiment":"negative","tone":-0.41999998688697815,"political":0.07000000029802322},{"id":"n_bacl6r7zvgpgs63o5w4a","seq":9910875,"kind":"article","title":"GLP-1 weight loss drugs can cause blindness","url":"https://foxsanantonio.com/newsletter-daily/glp-1-weight-loss-drugs-can-cause-blindness-ozempic-wegovy-mounjaro-zepbound-foundayo-nonarteritic-anterior-ischemic-optic-neuropathy-naion","published":"2026-11-11T13:54:00Z","seen":"2026-11-11T15:42:10Z","lang":"en","country":"US","source":{"id":"foxsanantonio.com","name":"foxsanantonio.com","domain":"foxsanantonio.com","outlet":{"wikidata":"Q6324711","name":"KABB","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8100000023841858,"sentiment":"negative","tone":-0.9100000262260437,"political":0.03999999910593033},{"id":"n_3ds3hcguchvxc7xpzi7a","seq":9946456,"kind":"article","title":"GLP-1 weight loss drugs can cause blindness","url":"https://news4sanantonio.com/news/local/glp-1-weight-loss-drugs-can-cause-blindness-ozempic-wegovy-mounjaro-zepbound-foundayo-nonarteritic-anterior-ischemic-optic-neuropathy-naion","published":"2026-11-11T13:54:00Z","seen":"2026-11-11T17:19:05Z","lang":"en","country":"US","source":{"id":"news4sanantonio.com","name":"news4sanantonio.com","domain":"news4sanantonio.com","outlet":{"wikidata":"Q7953728","name":"WOAI-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8100000023841858,"sentiment":"negative","tone":-0.9100000262260437,"political":0.03999999910593033},{"id":"n_s26agsrt57hxd5mdvoeq","seq":10073196,"kind":"article","title":"GLP-1 weight loss drugs can cause blindness","url":"https://abc7amarillo.com/news/local/glp-1-weight-loss-drugs-can-cause-blindness-ozempic-wegovy-mounjaro-zepbound-foundayo-nonarteritic-anterior-ischemic-optic-neuropathy-naion","published":"2026-11-11T13:54:00Z","seen":"2026-11-11T23:25:00Z","lang":"en","country":"US","source":{"id":"abc7amarillo.com","name":"abc7amarillo.com","domain":"abc7amarillo.com","outlet":{"wikidata":"Q6340051","name":"KVII-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8100000023841858,"sentiment":"negative","tone":-0.9100000262260437,"political":0.03999999910593033},{"id":"n_mvn2ztchv7lelsa55w6q","seq":9842670,"kind":"article","title":"FDA requires safety label changes for GLP-1s over risk for eye condition","url":"https://www.kxan.com/news/fda-requires-safety-label-changes-for-glp-1s-over-risk-for-eye-condition","summary":"NAION is often called an “eye stroke” because it occurs when blood flow to the optic nerve is reduced.","published":"2026-11-11T12:20:24Z","seen":"2026-11-11T12:25:30Z","lang":"en","country":"US","source":{"id":"kite-kxan-com-6bd633","name":"kxan.com","domain":"kxan.com","outlet":{"wikidata":"Q6341047","name":"KXAN-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"kite-kxan-com-6bd633","topics":["austin-tx","national news","news","top stories"],"authors":["Zach Kaplan"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q5572286","name":"glucagon-like peptide-1 agonist","type":"other"}],"image":"https://www.kxan.com/wp-content/uploads/sites/40/2026/11/GettyImages-2279484867_693208-e1783009938301_65d91c.jpg?w=900","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.5600000023841858,"sentiment":"negative","tone":-0.49000000953674316,"political":0.12999999523162842},{"id":"n_dbxg3gjhbok24vvmpxwq","seq":9832993,"kind":"article","title":"Risk of Vision Loss Prompts FDA to Require Warning on GLP-1 Drugs","url":"https://www.everydayhealth.com/obesity/fda-requires-glp-1s-to-carry-warning-about-rare-risk-of-vision-loss","published":"2026-11-11T11:45:00Z","seen":"2026-11-11T11:49:44Z","lang":"en","country":"US","source":{"id":"everydayhealth.com","name":"everydayhealth.com","domain":"everydayhealth.com","outlet":{"wikidata":"Q5417806","name":"Everyday Health","type":"website","country":"US","designations":["business","news website","public company"]}},"via":"gdelt-gkg-english","topics":["economy","health","education"],"authors":["Don Rauf"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8199999928474426,"sentiment":"negative","tone":-0.8799999952316284,"political":0.10000000149011612},{"id":"n_gi3vogziatd53wsvrnmq","seq":9894385,"kind":"article","title":"Φάρμακα αδυνατίσματος - GLP-1: Νέα προειδοποίηση για σπάνια παρενέργεια που μπορεί να οδηγήσει σε απώλεια όρασης - HuffPost","url":"https://www.huffingtonpost.gr/diethnes/farmaka-adynatismatos-glp-1-nea-proeidopoiisi-gia-spania-parenergeia-pou-borei-na-odigisei-se-apoleia-orasis","published":"2026-11-11T11:36:00Z","seen":"2026-11-11T14:50:24Z","lang":"el","country":"GR","source":{"id":"huffingtonpost.gr","name":"huffingtonpost.gr","domain":"huffingtonpost.gr","outlet":{"wikidata":"Q104413855","name":"HuffPost Greece","type":"newspaper","country":"GR","designations":["online newspaper"]}},"via":"gdelt-gkg-translingual","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.75,"sentiment":"negative","tone":-0.7799999713897705,"political":0.09000000357627869},{"id":"n_32vwteioga6luto6msoa","seq":9832076,"kind":"article","title":"FDA Adds Vision Loss Warning to All GLP-1 Drugs","url":"https://english.pravda.ru/news/world/172341-fda-glp1-drug-vision-loss-warning","published":"2026-11-11T10:13:00Z","seen":"2026-11-11T11:47:30Z","lang":"en","country":"RU","source":{"id":"english.pravda.ru","name":"english.pravda.ru","domain":"english.pravda.ru"},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Oksana Anikina","Marina Lebedeva"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.75,"sentiment":"negative","tone":-0.6800000071525574,"political":0.11999999731779099},{"id":"n_3er3h4sfx7fj7a2vbwpa","seq":9821016,"kind":"article","title":"Φάρμακα GLP-1: Προειδοποίηση FDA για σπάνια πάθηση που μπορεί να προκαλέσει τύφλωση","url":"https://www.ertnews.gr/eidiseis/epistimi/evzoia/ygeia/farmaka-glp-1-proeidopoiisi-fda-gia-spania-pathisi-pou-mporei-na-prokalesei-tyflosi","summary":"Νέες προειδοποιήσεις για τον κίνδυνο εμφάνισης μιας σπάνιας οφθαλμολογικής πάθησης, η οποία μπορεί να οδηγήσει σε αιφνίδια και μόνιμη απώλεια όρασης, ζητούν οι αμερικανικές αρχές να προστεθούν σε δημοφιλή φάρμακα για την παχυσαρκία και τον διαβήτη, όπως τα Ozempic, Wegovy, Mounjaro και Zepbound. Οι ειδικοί διευκρινίζουν, ωστόσο, ότι ο κίνδυνος είναι μικρός και δεν έχει ... Περισσότερα www.ertnews.gr","published":"2026-11-11T10:07:00Z","seen":"2026-11-11T11:16:05Z","lang":"el","country":"GR","source":{"id":"kite-ertnews-gr-a659c3","name":"ertnews.gr","domain":"ertnews.gr"},"via":"kite-ertnews-gr-a659c3","topics":["ειδησεις","ροη ειδησεων","υγεία","αδυνάτισμα","φάρμακα"],"authors":["Συντακτική ομάδα ertnews.gr"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8999999761581421,"sentiment":"neutral","tone":-0.44999998807907104,"political":0.05000000074505806},{"id":"n_hejrbctbdiu4fksdpzga","seq":9805931,"kind":"article","title":"Φάρμακα GLP-1: Νέα προειδοποίηση για σπάνια παρενέργεια που μπορεί να οδηγήσει σε απώλεια όρασης","title_en":"GLP-1 drugs: New warning about rare side effect that may lead to vision loss","url":"https://www.newsbomb.gr/ygeia/farmako/story/1775735/farmaka-glp-1-nea-proeidopoiisi-gia-spania-parenergeia-pou-borei-na-odigisei-se-apoleia-orasis","summary":"Η απόφαση του αμερικανικού Οργανισμού Τροφίμων και Φαρμάκων (FDA) Περισσότερα...","published":"2026-11-11T09:51:11Z","seen":"2026-11-11T10:30:01Z","lang":"el","country":"GR","source":{"id":"kite-newsbomb-gr-d75565","name":"newsbomb.gr","domain":"newsbomb.gr","outlet":{"wikidata":"Q105296698","name":"Q105296698","type":"website","country":"GR","designations":["website"]}},"via":"kite-newsbomb-gr-d75565","topics":["φαρμακο"],"authors":["author"],"entities":[{"id":"Q424611","name":"glucagon-like peptide-1","type":"other"}],"mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.75,"sentiment":"negative","tone":-0.7099999785423279,"political":0.07000000029802322},{"id":"n_z3wkdyfmsqvugeaxfoia","seq":9870871,"kind":"article","title":"FDA Warns GLP-1 Drugs May Carry Rare Vision Loss Risk","url":"https://talkradio960.com/ixp/33/p/fda-glp-1-naion-warning","published":"2026-11-11T08:46:00Z","seen":"2026-11-11T13:46:34Z","lang":"en","country":"US","source":{"id":"talkradio960.com","name":"talkradio960.com","domain":"talkradio960.com","outlet":{"wikidata":"Q6336952","name":"KROF","type":"broadcaster","country":"US","designations":["radio station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Bruce Mikells"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"negative","tone":-0.30000001192092896,"political":0.14000000059604645},{"id":"n_kzf22vylrqpjenowif6q","seq":9871743,"kind":"article","title":"FDA Warns GLP-1 Drugs May Carry Rare Vision Loss Risk","url":"https://999ktdy.com/ixp/33/p/fda-glp-1-naion-warning","published":"2026-11-11T08:46:00Z","seen":"2026-11-11T13:48:36Z","lang":"en","country":"US","source":{"id":"999ktdy.com","name":"999ktdy.com","domain":"999ktdy.com","outlet":{"wikidata":"Q6338590","name":"KTDY","type":"broadcaster","country":"US","designations":["radio station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Bruce Mikells"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"negative","tone":-0.30000001192092896,"political":0.14000000059604645},{"id":"n_uwxc33afpao7xf4hm2oq","seq":9878617,"kind":"article","title":"FDA Warns GLP-1 Drugs May Carry Rare Vision Loss Risk","url":"https://kpel965.com/ixp/33/p/fda-glp-1-naion-warning","published":"2026-11-11T08:46:00Z","seen":"2026-11-11T14:05:58Z","lang":"en","country":"US","source":{"id":"kpel965.com","name":"kpel965.com","domain":"kpel965.com","outlet":{"wikidata":"Q6335538","name":"KPEL-FM","type":"broadcaster","country":"US","designations":["radio station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Bruce Mikells"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"negative","tone":-0.30000001192092896,"political":0.14000000059604645},{"id":"n_bp7xkvnbtr6xexao5kfa","seq":9800121,"kind":"article","title":"FDA Warns GLP-1 Drugs May Carry Rare Vision Loss Risk","url":"https://973thedawg.com/fda-glp-1-naion-warning","published":"2026-11-11T06:53:00Z","seen":"2026-11-11T10:01:47Z","lang":"en","country":"US","source":{"id":"973thedawg.com","name":"973thedawg.com","domain":"973thedawg.com","outlet":{"wikidata":"Q6333439","name":"KMDL","type":"broadcaster","country":"US","designations":["radio station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Bruce Mikells"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"negative","tone":-0.30000001192092896,"political":0.14000000059604645},{"id":"n_nkmhuupn6g4tvdmjdchq","seq":9945323,"kind":"article","title":"FDA Warns GLP-1 Drugs May Carry Rare Vision Loss Risk","url":"https://mykiss1031.com/ixp/33/p/fda-glp-1-naion-warning","published":"2026-11-11T06:53:00Z","seen":"2026-11-11T17:15:49Z","lang":"en","country":"US","source":{"id":"mykiss1031.com","name":"mykiss1031.com","domain":"mykiss1031.com","outlet":{"wikidata":"Q14710781","name":"KSSM","type":"broadcaster","country":"US","designations":["radio station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Bruce Mikells"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"negative","tone":-0.30000001192092896,"political":0.14000000059604645},{"id":"n_tpmk47xyjfdha2di7wka","seq":9950109,"kind":"article","title":"FDA Warns GLP-1 Drugs May Carry Rare Vision Loss Risk","url":"https://myb106.com/ixp/33/p/fda-glp-1-naion-warning","published":"2026-11-11T06:53:00Z","seen":"2026-11-11T17:25:18Z","lang":"en","country":"US","source":{"id":"myb106.com","name":"myb106.com","domain":"myb106.com","outlet":{"wikidata":"Q6335099","name":"KOOC","type":"broadcaster","country":"US","designations":["radio station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Bruce Mikells"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"negative","tone":-0.30000001192092896,"political":0.14000000059604645},{"id":"n_mu2btgwrbq56emtylagq","seq":9976922,"kind":"article","title":"FDA Warns GLP-1 Drugs May Carry Rare Vision Loss Risk","url":"https://kfox95.com/ixp/33/p/fda-glp-1-naion-warning","published":"2026-11-11T06:53:00Z","seen":"2026-11-11T18:33:58Z","lang":"en","country":"US","source":{"id":"kfox95.com","name":"kfox95.com","domain":"kfox95.com","outlet":{"wikidata":"Q14710547","name":"KAFX-FM","type":"broadcaster","country":"US","designations":["radio station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Bruce Mikells"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"negative","tone":-0.30000001192092896,"political":0.14000000059604645},{"id":"n_zpl644uqgj54gkb4poba","seq":9977690,"kind":"article","title":"FDA Warns GLP-1 Drugs May Carry Rare Vision Loss Risk","url":"https://us105fm.com/ixp/33/p/fda-glp-1-naion-warning","published":"2026-11-11T06:53:00Z","seen":"2026-11-11T18:37:29Z","lang":"en","country":"US","source":{"id":"us105fm.com","name":"us105fm.com","domain":"us105fm.com","outlet":{"wikidata":"Q6339746","name":"KUSJ","type":"broadcaster","country":"US","designations":["radio station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Bruce Mikells"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"negative","tone":-0.30000001192092896,"political":0.14000000059604645},{"id":"n_qq4a4nthhyrs5hydd76a","seq":10024629,"kind":"article","title":"FDA Warns GLP-1 Drugs May Carry Rare Vision Loss Risk","url":"https://k945.com/ixp/33/p/fda-glp-1-naion-warning","published":"2026-11-11T06:53:00Z","seen":"2026-11-11T21:09:35Z","lang":"en","country":"US","source":{"id":"k945.com","name":"k945.com","domain":"k945.com","outlet":{"wikidata":"Q6337243","name":"KRUF","type":"broadcaster","country":"US","designations":["radio station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Bruce Mikells"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"negative","tone":-0.30000001192092896,"political":0.14000000059604645},{"id":"n_dcqww2j4ymdvktfh3q3a","seq":9827821,"kind":"article","title":"Popular GLP-1 Weight Loss Drugs Can Cause Permanent Blindness - US FDA - Trak.in - Indian Business of Tech, Mobile & Startups","url":"https://trak.in/stories/popular-glp-1-weight-loss-drugs-can-cause-permanent-blindness-us-fda","published":"2026-11-11T06:34:00Z","seen":"2026-11-11T11:36:46Z","lang":"en","country":"IN","source":{"id":"trak.in","name":"trak.in","domain":"trak.in"},"via":"gdelt-gkg-english","topics":["economy","education","health"],"authors":["Mohul Ghosh"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6899999976158142,"sentiment":"negative","tone":-0.6899999976158142,"political":0.03999999910593033},{"id":"n_vuaaje5ma7vqy52fqqna","seq":9742067,"kind":"article","title":"GLP-1 ilaçları için yeni bir görme kaybı uyarısı yayınlandı","title_en":"New warning about vision loss for GLP-1 drugs","url":"https://www.haberturk.com/saglik/fda-glp-1-ilaclari-icin-yeni-bir-gorme-kaybi-uyarisi-yayinladi-haberler-3926432","summary":"ABD Gıda ve İlaç Dairesi (FDA), Ozempic, Wegovy ve Mounjaro dahil diyabet tedavisinde ve zayıflama amacıyla kullanılan popüler ilaçların, kalıcı görme kaybına yol açabilen nadir bir göz rahatsızlığı riskini artırabileceği uyarısıyla ilaçların güvenlik etiketlerine yeni uyarılar eklenmesini zorunlu kıldı","published":"2026-11-11T06:26:44Z","seen":"2026-11-11T06:59:01Z","lang":"tr","country":"TR","source":{"id":"kite-haberturk-com-c971a0","name":"haberturk.com","domain":"haberturk.com","outlet":{"wikidata":"Q5636741","name":"Habertürk","type":"newspaper","country":"TR","designations":["newspaper"]}},"via":"kite-haberturk-com-c971a0","image":"https://im.haberturk.com/l/2026/11/11/ver1794378393/3926432/jpg/200x113","mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.800000011920929,"sentiment":"negative","tone":-0.7300000190734863,"political":0.05000000074505806},{"id":"n_xh7ar2tz6bomspzwymfa","seq":9740679,"kind":"article","title":"FDA flags possible risk of rare eye condition with GLP-1 drugs, orders new safety warning","url":"https://www.thehindubusinessline.com/latest-news/fda-flags-possible-risk-of-rare-eye-condition-with-glp-1-drugs-orders-new-safety-warning/article71688508.ece","published":"2026-11-11T06:24:00Z","seen":"2026-11-11T06:43:08Z","lang":"en","country":"IN","source":{"id":"thehindubusinessline.com","name":"thehindubusinessline.com","domain":"thehindubusinessline.com","outlet":{"wikidata":"Q279739","name":"Business Line","type":"newspaper","country":"IN","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q424611","name":"glucagon-like peptide-1","type":"other"}],"mentions":3,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6200000047683716,"sentiment":"negative","tone":-0.7400000095367432,"political":0.11999999731779099},{"id":"n_b3kaj7ugt4iwdex6lqda","seq":9783640,"kind":"article","title":"Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness","url":"https://www.kbc.co.ke/makers-of-glp-1-drugs-ordered-to-add-warnings-about-rare-eye-condition-that-can-lead-to-blindness","summary":"There is no known treatment to reverse vision loss caused by NAION. It is the most common cause of acute optic nerve injury in people over 50 years old, according to the academy. The post Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness appeared first on KBC Digital .","published":"2026-11-11T05:49:37Z","seen":"2026-11-11T09:22:04Z","lang":"en","country":"KE","source":{"id":"kite-kbc-co-ke-786bda","name":"kbc.co.ke","domain":"kbc.co.ke","outlet":{"wikidata":"Q6392548","name":"Kenya Broadcasting Corporation","type":"other","country":"KE","designations":["broadcast network"]}},"via":"kite-kbc-co-ke-786bda","topics":["human interest","lifestyle"],"authors":["BBC"],"image":"https://www.kbc.co.ke/wp-content/uploads/2026/11/Weight-loss-e.jpg","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6800000071525574,"sentiment":"negative","tone":-0.47999998927116394,"political":0.05000000074505806},{"id":"n_7cjzuajf3nxdrwyamuia","seq":9716827,"kind":"article","title":"Korea warns of rare vision-loss risk linked to GLP-1 drugs","url":"https://www.koreatimes.co.kr/southkorea/society/20261111/korea-warns-of-rare-vision-loss-risk-linked-to-glp-1-drugs","summary":"The Ministry of Food and Drug Safety issued a safety alert Wednesday to medical professionals and patients over a potential risk of a rare eye condition associated with GLP-1 obesity drugs, including popular obesity treatments Wegovy and Mounjaro. The move follows safety measures by overseas regulators concerning nonarteritic anterior ischemic optic neuropathy (NAION), a condition caused by reduced blood flow to the optic nerve that can lead to sudden, potentially permanent…","published":"2026-11-11T04:57:03Z","seen":"2026-11-11T05:02:00Z","lang":"en","source":{"id":"kite-koreatimes-co-kr-c6eccf","name":"koreatimes.co.kr","domain":"feed.koreatimes.co.kr"},"via":"kite-koreatimes-co-kr-c6eccf","topics":["asia"],"authors":["author"],"image":"https://newsimg.koreatimes.co.kr/2026/11/11/f94f082d-7715-4f89-880e-2be99fbbfe3b.jpg","mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6700000166893005,"sentiment":"negative","tone":-0.6800000071525574,"political":0.33000001311302185},{"id":"n_nbf5nubhhpr2fxymvjya","seq":9697240,"kind":"article","title":"Tuesday Health Report: FDA mandates warning for rare eye condition on popular GLP-1 medications","url":"https://www.wbrz.com/news/tuesday-health-report-fda-mandates-warning-for-rare-eye-condition-on-popular-glp-1-medications","published":"2026-11-11T03:15:00Z","seen":"2026-11-11T03:27:03Z","lang":"en","country":"US","source":{"id":"wbrz.com","name":"wbrz.com","domain":"wbrz.com","outlet":{"wikidata":"Q7947409","name":"WBRZ-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8500000238418579,"sentiment":"neutral","tone":-0.5299999713897705,"political":0.10999999940395355},{"id":"n_d4xcllggmghn4tg6md6q","seq":9691370,"kind":"article","title":"GLP-1 drugs to carry warning about rare vision-loss side effect, FDA says","url":"https://www.cbsnews.com/video/glp-1-drugs-to-carry-warning-about-rare-vision-loss-side-effect-fda-says","summary":"GLP-1 drugs will now carry a warning for a rare, but potentially dangerous side effect that can lead to vision loss, the FDA says. Dr. Rachel Pessah-Pollack joins CBS News to discuss.","published":"2026-11-11T01:59:54Z","seen":"2026-11-11T03:02:00Z","lang":"en","country":"US","source":{"id":"kite-cbsnews-com-062e7e","name":"cbsnews.com","domain":"cbsnews.com","outlet":{"wikidata":"Q861764","name":"Q861764","type":"broadcaster","country":"US","designations":["specialty channel","television production company"]}},"via":"kite-cbsnews-com-062e7e","topics":["colorado","new-york-city"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.800000011920929,"sentiment":"negative","tone":-0.4399999976158142,"political":0.15000000596046448},{"id":"n_fmyfmkphd36lp6c2uhsa","seq":9700032,"kind":"article","title":"FDA arah pengeluar ubat kurus GLP-1 dedah risiko masalah mata","url":"https://www.utusan.com.my/luar-negara/2026/11/fda-arah-pengeluar-ubat-kurus-glp-1-dedah-risiko-masalah-mata","published":"2026-11-11T01:30:00Z","seen":"2026-11-11T03:44:00Z","lang":"ms","country":"MY","source":{"id":"utusan.com.my","name":"utusan.com.my","domain":"utusan.com.my","outlet":{"wikidata":"Q863351","name":"Utusan Malaysia","type":"newspaper","country":"MY","designations":["newspaper"]}},"via":"gdelt-gkg-translingual","topics":["economy","health","science"],"authors":["ISZ YUSLIZA"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6399999856948853,"sentiment":"negative","tone":-0.8100000023841858,"political":0.10000000149011612},{"id":"n_bfnkbwhcqsfhobqcfqhq","seq":9687683,"kind":"article","title":"熱門 GLP-1 藥物增視力喪失風險 美國FDA要求加註警語","url":"https://n.yam.com/Article/20261111847445","published":"2026-11-11T00:54:00Z","seen":"2026-11-11T02:32:00Z","lang":"zh","source":{"id":"yam.com","name":"yam.com","domain":"yam.com","outlet":{"wikidata":"Q15912872","name":"Yam","type":"other","designations":["business"]}},"via":"gdelt-gkg-translingual","topics":["health","economy","politics"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.5099999904632568,"sentiment":"negative","tone":-0.6000000238418579,"political":0.11999999731779099},{"id":"n_d4mumogt766tzdiiljcq","seq":9674106,"kind":"article","title":"FDA requires GLP-1 drugs to carry warning labels about rare risk of vision loss","url":"https://www.phillyvoice.com/glp1-weight-loss-drugs-vision-loss-fda-warnings","published":"2026-11-11T00:45:00Z","seen":"2026-11-11T01:33:00Z","lang":"en","source":{"id":"phillyvoice.com","name":"phillyvoice.com","domain":"phillyvoice.com"},"via":"gdelt-gkg-english","topics":["economy","politics","health"],"authors":["Courtenay Harris Bond"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7699999809265137,"sentiment":"neutral","tone":-0.4099999964237213,"political":0.09000000357627869},{"id":"n_gpkluzjvlovykb2l5u2a","seq":9672466,"kind":"article","title":"美药管局警示GLP-1类降糖药可能增加眼病风险","url":"https://finance.sina.com.cn/tech/roll/2026-11-11/doc-iniyiauk2238258.shtml","published":"2026-11-11T00:30:00Z","seen":"2026-11-11T01:29:01Z","lang":"zh","country":"CN","source":{"id":"sina.com.cn","name":"sina.com.cn","domain":"sina.com.cn","outlet":{"wikidata":"Q938668","name":"Sina Corporation","type":"other","country":"CN","designations":["business","public company"]}},"via":"gdelt-gkg-translingual","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8899999856948853,"sentiment":"negative","tone":-0.7300000190734863,"political":0.07999999821186066},{"id":"n_tubhaw7fbgdkpqmvifua","seq":9678477,"kind":"article","title":"GLP-1 drugs carry risk of rare but serious eye condition – a physician studying these medicines explains the potential side effect","url":"https://theconversation.com/glp-1-drugs-carry-risk-of-rare-but-serious-eye-condition-a-physician-studying-these-medicines-explains-the-potential-side-effect-296237","published":"2026-11-11T00:27:00Z","seen":"2026-11-11T01:45:19Z","lang":"en","country":"AU","source":{"id":"theconversation.com","name":"theconversation.com","domain":"theconversation.com","outlet":{"wikidata":"Q7727516","name":"The Conversation","type":"website","country":"AU","designations":["communications media","dot-com company","nonprofit organization","open-content news site","website"]}},"via":"gdelt-gkg-english","topics":["economy","health","science"],"authors":["Ziyad Al-Aly"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7900000214576721,"sentiment":"neutral","tone":-0.4399999976158142,"political":0.07000000029802322},{"id":"n_mtmedh6tm54f7wxedq2a","seq":9662776,"kind":"article","title":"FDA requires blindness warning label on GLP-1 drugs","url":"https://www.azfamily.com/2026/11/10/fda-requires-blindness-warning-label-glp-1-drugs","published":"2026-11-11T00:15:00Z","seen":"2026-11-11T00:47:05Z","lang":"en","country":"US","source":{"id":"azfamily.com","name":"azfamily.com","domain":"azfamily.com","outlet":{"wikidata":"Q3191480","name":"KPHO-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7300000190734863,"sentiment":"negative","tone":-0.5299999713897705,"political":0.10999999940395355},{"id":"n_rf6q7mtnwh55tzs5lpua","seq":9661811,"kind":"article","title":"GLP-1 Drugs Linked to Rare but Serious Eye Condition","url":"https://www.miragenews.com/glp-1-drugs-linked-to-rare-but-serious-eye-1775230","published":"2026-11-11T00:00:00Z","seen":"2026-11-11T00:44:44Z","lang":"en","source":{"id":"miragenews.com","name":"miragenews.com","domain":"miragenews.com"},"via":"gdelt-gkg-english","topics":["science","economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6399999856948853,"sentiment":"neutral","tone":-0.3700000047683716,"political":0.05000000074505806},{"id":"n_p554fep6shxoqecbobxq","seq":9649496,"kind":"article","title":"Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead ...","url":"https://article.wn.com/view/2026/11/10/Makers_of_GLP1_drugs_ordered_to_add_warnings_about_rare_eye__6","published":"2026-11-10T23:30:00Z","seen":"2026-11-10T23:34:41Z","lang":"en","country":"US","source":{"id":"wn.com","name":"wn.com","domain":"wn.com","outlet":{"wikidata":"Q1317947","name":"World News Network","type":"website","country":"US","designations":["business","news aggregation website"]}},"via":"gdelt-gkg-english","topics":["economy"],"authors":["system"],"entities":[{"id":"Q424611","name":"glucagon-like peptide-1","type":"other"}],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6200000047683716,"sentiment":"neutral","tone":-0.44999998807907104,"political":0.05999999865889549},{"id":"n_r5atfqm46g3bql7ifsya","seq":9661473,"kind":"article","title":"FDA adds rare vision-loss warning to popular GLP-1 drugs","url":"https://www.dcourier.com/features/healthcare-focus/fda-adds-rare-vision-loss-warning-to-popular-glp-1-drugs/article_feecdf47-9740-4766-807b-0a0fd8208795.html","published":"2026-11-10T23:15:00Z","seen":"2026-11-11T00:42:00Z","lang":"en","source":{"id":"dcourier.com","name":"dcourier.com","domain":"dcourier.com","outlet":{"wikidata":"Q7728640","name":"The Daily Courier","type":"newspaper","designations":["business","daily newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["MATTHEW PERRONE","AP Health Writer"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7900000214576721,"sentiment":"negative","tone":-0.27000001072883606,"political":0.07000000029802322},{"id":"n_p74p5m5mktw5kba5ut6a","seq":9944474,"kind":"article","title":"GLP-1 drugs carry risk of rare but serious eye condition – a physician studying these medicines explains the potential side effect","url":"https://www.lebanondemocrat.com/lifestyles/health/glp-1-drugs-carry-risk-of-rare-but-serious-eye-condition-a-physician-studying-these/article_7c7f2cea-a6b1-53bf-aa4e-e74f2d0f1344.html","published":"2026-11-10T23:07:00Z","seen":"2026-11-11T17:15:49Z","lang":"en","source":{"id":"lebanondemocrat.com","name":"lebanondemocrat.com","domain":"lebanondemocrat.com","outlet":{"wikidata":"Q6511079","name":"Lebanon Democrat","type":"newspaper","designations":["newspaper","periodical"]}},"via":"gdelt-gkg-english","topics":["economy","science","health"],"authors":["Ziyad Al-Aly","Washington University in St. Louis"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7900000214576721,"sentiment":"neutral","tone":-0.46000000834465027,"political":0.07000000029802322},{"id":"n_ots2wdycvashiraehdvq","seq":9949507,"kind":"article","title":"GLP-1 drugs carry risk of rare but serious eye condition – a physician studying these medicines explains the potential side effect","url":"https://www.fairfieldsuntimes.com/arts_and_entertainment/health/glp-1-drugs-carry-risk-of-rare-but-serious-eye-condition-a-physician-studying-these/article_7a2d6131-8544-5711-aecf-b25097b08362.html","published":"2026-11-10T23:07:00Z","seen":"2026-11-11T17:25:18Z","lang":"en","country":"US","source":{"id":"fairfieldsuntimes.com","name":"fairfieldsuntimes.com","domain":"fairfieldsuntimes.com","outlet":{"wikidata":"Q28126627","name":"Fairfield Sun Times","type":"newspaper","country":"US","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","science","health"],"authors":["Ziyad Al-Aly","Washington University in St. Louis"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7900000214576721,"sentiment":"neutral","tone":-0.46000000834465027,"political":0.07000000029802322},{"id":"n_rnxteaduwcy4iw3jnq6q","seq":9976882,"kind":"article","title":"GLP-1 drugs carry risk of rare but serious eye condition – a physician studying these medicines explains the potential side effect","url":"https://www.vtcng.com/shelburnenews/state_and_world/health_news/glp-1-drugs-carry-risk-of-rare-but-serious-eye-condition-a-physician-studying-these/article_52ee26c7-4b37-5166-8c06-9d8b0a57c344.html","published":"2026-11-10T23:07:00Z","seen":"2026-11-11T18:33:58Z","lang":"en","country":"US","source":{"id":"vtcng.com","name":"vtcng.com","domain":"vtcng.com","outlet":{"wikidata":"Q96419617","name":"Vermont Community Newspaper Group","type":"other","country":"US","designations":["media company"]}},"via":"gdelt-gkg-english","topics":["economy","health","science"],"authors":["Ziyad Al-Aly","Washington University in St. Louis"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7900000214576721,"sentiment":"neutral","tone":-0.46000000834465027,"political":0.07000000029802322},{"id":"n_eaopzq5dkxfh2yjfha2a","seq":9662981,"kind":"article","title":"FDA requiring vision loss warnings on GLP-1 medications","url":"https://americanbazaaronline.com/2026/11/10/fda-requiring-vision-loss-warnings-on-glp-1-medications-491996","published":"2026-11-10T22:49:00Z","seen":"2026-11-11T00:47:05Z","lang":"en","source":{"id":"americanbazaaronline.com","name":"americanbazaaronline.com","domain":"americanbazaaronline.com"},"via":"gdelt-gkg-english","topics":["health","economy"],"authors":["Keerthi Ramesh"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.6399999856948853,"political":0.10000000149011612},{"id":"n_6euyuqdf32xchxppt6sa","seq":9674441,"kind":"article","title":"FDA requires new warning labels on GLP-1 drugs over rare eye stroke vision risk","url":"https://local12.com/health/health-updates/fda-requires-new-warning-labels-glp-1-drugs-rare-eye-stroke-vision-risk-diabetes-weight-loss-blood-pressure-medication","published":"2026-11-10T22:06:00Z","seen":"2026-11-11T01:34:48Z","lang":"en","country":"US","source":{"id":"local12.com","name":"local12.com","domain":"local12.com","outlet":{"wikidata":"Q14716868","name":"WKRC-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"neutral","tone":-0.75,"political":0.23999999463558197},{"id":"n_jyd3izetbyhiugdemitq","seq":9944528,"kind":"article","title":"FDA requires new warning labels on GLP-1 drugs over rare eye stroke vision risk","url":"https://fox56.com/news/nation-world/fda-requires-new-warning-labels-glp-1-drugs-rare-eye-stroke-vision-risk-diabetes-weight-loss-blood-pressure-medication","published":"2026-11-10T22:06:00Z","seen":"2026-11-11T17:15:49Z","lang":"en","country":"US","source":{"id":"fox56.com","name":"fox56.com","domain":"fox56.com","outlet":{"wikidata":"Q3564757","name":"WOLF-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"neutral","tone":-0.75,"political":0.23999999463558197},{"id":"n_gs64ihdwu4vmdq7wbcoa","seq":9945156,"kind":"article","title":"FDA requires new warning labels on GLP-1 drugs over rare eye stroke vision risk","url":"https://wcyb.com/news/nation-world/fda-requires-new-warning-labels-glp-1-drugs-rare-eye-stroke-vision-risk-diabetes-weight-loss-blood-pressure-medication","published":"2026-11-10T22:06:00Z","seen":"2026-11-11T17:15:49Z","lang":"en","country":"US","source":{"id":"wcyb.com","name":"wcyb.com","domain":"wcyb.com","outlet":{"wikidata":"Q7948227","name":"WCYB-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"neutral","tone":-0.75,"political":0.23999999463558197},{"id":"n_bukdenpkynxot64cz7wq","seq":9945219,"kind":"article","title":"FDA requires new warning labels on GLP-1 drugs over rare eye stroke vision risk","url":"https://upnorthlive.com/news/nation-world/fda-requires-new-warning-labels-glp-1-drugs-rare-eye-stroke-vision-risk-diabetes-weight-loss-blood-pressure-medication","published":"2026-11-10T22:06:00Z","seen":"2026-11-11T17:15:49Z","lang":"en","country":"US","source":{"id":"upnorthlive.com","name":"upnorthlive.com","domain":"upnorthlive.com","outlet":{"wikidata":"Q7949975","name":"WGTU","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"neutral","tone":-0.75,"political":0.23999999463558197},{"id":"n_bgwvhk6kjaulieqrfdva","seq":9945353,"kind":"article","title":"FDA requires new warning labels on GLP-1 drugs over rare eye stroke vision risk","url":"https://wwmt.com/news/nation-world/fda-requires-new-warning-labels-glp-1-drugs-rare-eye-stroke-vision-risk-diabetes-weight-loss-blood-pressure-medication","published":"2026-11-10T22:06:00Z","seen":"2026-11-11T17:15:49Z","lang":"en","country":"US","source":{"id":"wwmt.com","name":"wwmt.com","domain":"wwmt.com","outlet":{"wikidata":"Q7957379","name":"WWMT","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"neutral","tone":-0.75,"political":0.23999999463558197},{"id":"n_lm2kvzpiprwyvxgaljsq","seq":9945378,"kind":"article","title":"FDA requires new warning labels on GLP-1 drugs over rare eye stroke vision risk","url":"https://ktul.com/news/nation-world/fda-requires-new-warning-labels-glp-1-drugs-rare-eye-stroke-vision-risk-diabetes-weight-loss-blood-pressure-medication","published":"2026-11-10T22:06:00Z","seen":"2026-11-11T17:15:49Z","lang":"en","country":"US","source":{"id":"ktul.com","name":"ktul.com","domain":"ktul.com","outlet":{"wikidata":"Q6339228","name":"KTUL","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["health","economy"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"neutral","tone":-0.75,"political":0.23999999463558197},{"id":"n_ocpmv7rxqd6gnfzrjf4a","seq":9945847,"kind":"article","title":"FDA requires new warning labels on GLP-1 drugs over rare eye stroke vision risk","url":"https://turnto10.com/news/nation-world/fda-requires-new-warning-labels-glp-1-drugs-rare-eye-stroke-vision-risk-diabetes-weight-loss-blood-pressure-medication","published":"2026-11-10T22:06:00Z","seen":"2026-11-11T17:19:05Z","lang":"en","country":"US","source":{"id":"turnto10.com","name":"turnto10.com","domain":"turnto10.com","outlet":{"wikidata":"Q14715947","name":"WJAR","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"neutral","tone":-0.75,"political":0.23999999463558197},{"id":"n_a4c6rvqoe3b2ac5jr6vq","seq":9945871,"kind":"article","title":"FDA requires new warning labels on GLP-1 drugs over rare eye stroke vision risk","url":"https://nbc24.com/news/nation-world/fda-requires-new-warning-labels-glp-1-drugs-rare-eye-stroke-vision-risk-diabetes-weight-loss-blood-pressure-medication","published":"2026-11-10T22:06:00Z","seen":"2026-11-11T17:19:05Z","lang":"en","country":"US","source":{"id":"nbc24.com","name":"nbc24.com","domain":"nbc24.com","outlet":{"wikidata":"Q7953665","name":"WNWO-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"neutral","tone":-0.75,"political":0.23999999463558197},{"id":"n_rcbyrdagsn6cbcmxygja","seq":9946450,"kind":"article","title":"FDA requires new warning labels on GLP-1 drugs over rare eye stroke vision risk","url":"https://fox11online.com/news/nation-world/fda-requires-new-warning-labels-glp-1-drugs-rare-eye-stroke-vision-risk-diabetes-weight-loss-blood-pressure-medication","published":"2026-11-10T22:06:00Z","seen":"2026-11-11T17:19:05Z","lang":"en","country":"US","source":{"id":"fox11online.com","name":"fox11online.com","domain":"fox11online.com","outlet":{"wikidata":"Q7952525","name":"WLUK-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"neutral","tone":-0.75,"political":0.23999999463558197},{"id":"n_3lsz7ashinqvqy7gkgrq","seq":9946517,"kind":"article","title":"FDA requires new warning labels on GLP-1 drugs over rare eye stroke vision risk","url":"https://news4sanantonio.com/news/nation-world/fda-requires-new-warning-labels-glp-1-drugs-rare-eye-stroke-vision-risk-diabetes-weight-loss-blood-pressure-medication","published":"2026-11-10T22:06:00Z","seen":"2026-11-11T17:19:05Z","lang":"en","country":"US","source":{"id":"news4sanantonio.com","name":"news4sanantonio.com","domain":"news4sanantonio.com","outlet":{"wikidata":"Q7953728","name":"WOAI-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"neutral","tone":-0.75,"political":0.23999999463558197},{"id":"n_awak2yi7q6rqq6riirya","seq":9946775,"kind":"article","title":"FDA requires new warning labels on GLP-1 drugs over rare eye stroke vision risk","url":"https://foxrochester.com/news/nation-world/fda-requires-new-warning-labels-glp-1-drugs-rare-eye-stroke-vision-risk-diabetes-weight-loss-blood-pressure-medication","published":"2026-11-10T22:06:00Z","seen":"2026-11-11T17:19:05Z","lang":"en","country":"US","source":{"id":"foxrochester.com","name":"foxrochester.com","domain":"foxrochester.com","outlet":{"wikidata":"Q7956590","name":"WUHF","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"neutral","tone":-0.75,"political":0.23999999463558197},{"id":"n_t7joqze7vjg74se3vewq","seq":9947032,"kind":"article","title":"FDA requires new warning labels on GLP-1 drugs over rare eye stroke vision risk","url":"https://kpic.com/news/nation-world/fda-requires-new-warning-labels-glp-1-drugs-rare-eye-stroke-vision-risk-diabetes-weight-loss-blood-pressure-medication","published":"2026-11-10T22:06:00Z","seen":"2026-11-11T17:19:05Z","lang":"en","source":{"id":"kpic.com","name":"kpic.com","domain":"kpic.com"},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"neutral","tone":-0.75,"political":0.23999999463558197},{"id":"n_ysvblg6wl7jas2bfdwiq","seq":9947055,"kind":"article","title":"FDA requires new warning labels on GLP-1 drugs over rare eye stroke vision risk","url":"https://katv.com/news/nation-world/fda-requires-new-warning-labels-glp-1-drugs-rare-eye-stroke-vision-risk-diabetes-weight-loss-blood-pressure-medication","published":"2026-11-10T22:06:00Z","seen":"2026-11-11T17:19:05Z","lang":"en","country":"US","source":{"id":"katv.com","name":"katv.com","domain":"katv.com","outlet":{"wikidata":"Q936908","name":"KATV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"neutral","tone":-0.75,"political":0.23999999463558197},{"id":"n_md57qy57jpzpbqplplwa","seq":9636030,"kind":"article","title":"Rare eye condition prompts new FDA warning on popular GLP-1 drugs","url":"https://medicalxpress.com/news/2026-11-rare-eye-condition-prompts-fda.html","summary":"The U.S. Food and Drug Administration (FDA) is requiring makers of Ozempic, Wegovy and similar drugs to warn of a rare eye condition that can cause vision loss.","published":"2026-11-10T22:00:08Z","seen":"2026-11-10T22:56:30Z","lang":"en","country":"IM","source":{"id":"kite-medicalxpress-com-b50135","name":"medicalxpress.com","domain":"medicalxpress.com","outlet":{"wikidata":"Q69053481","name":"Medical Xpress","type":"website","country":"IM","designations":["news aggregator","news website","website"]}},"via":"kite-medicalxpress-com-b50135","topics":["medicine"],"image":"https://scx1.b-cdn.net/csz/news/tmb/2026/eye-2.jpg","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8600000143051147,"sentiment":"negative","tone":-0.5899999737739563,"political":0.03999999910593033},{"id":"n_3qnn2cfwukfxhpmdrn7a","seq":9611295,"kind":"article","title":"FDA, GLP1 kilo verme ilaçları için körlük riski uyarısında bulundu","title_en":"FDA warns of blindness risk for GLP1 weight loss drugs","url":"https://www.trthaber.com/haber/dunya/fda-glp-1-kilo-verme-ilaclari-icin-korluk-riski-uyarisinda-bulundu-962864.html","summary":"Amerikan Gıda ve İlaç Dairesi FDA, Ozempic, Wegovy ve Mounjaro gibi popüler GLP1 sınıfı kilo verme ve diyabet ilaçlarının uyarı etiketlerine nadir görülen ve kalıcı körlüğe yol açabilen bir göz rahatsızlığı riskinin eklenmesini zorunlu kıldı.","published":"2026-11-10T21:23:00Z","seen":"2026-11-10T21:40:51Z","lang":"tr","country":"TR","source":{"id":"kite-trthaber-com-699107","name":"trthaber.com","domain":"trthaber.com","outlet":{"wikidata":"Q535725","name":"TRT Haber","type":"broadcaster","country":"TR","designations":["specialty channel","television station"]}},"via":"kite-trthaber-com-699107","topics":["dünya"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8100000023841858,"sentiment":"negative","tone":-0.7099999785423279,"political":0.07999999821186066},{"id":"n_krrhkzz3ffsccvyaf5fq","seq":9627896,"kind":"article","title":"FDA warns GLP-1s could increase risk of vision loss","url":"https://www.wfdd.org/health-safety/2026-11-10/fda-warns-glp-1s-could-increase-risk-of-vision-loss","published":"2026-11-10T21:00:00Z","seen":"2026-11-10T22:31:41Z","lang":"en","country":"US","source":{"id":"wfdd.org","name":"wfdd.org","domain":"wfdd.org","outlet":{"wikidata":"Q7949237","name":"WFDD","type":"broadcaster","country":"US","designations":["radio station"]}},"via":"gdelt-gkg-english","topics":["economy"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8199999928474426,"sentiment":"negative","tone":-0.8399999737739563,"political":0.11999999731779099},{"id":"n_sobdc7c7p52ifzxu5tcq","seq":9678669,"kind":"article","title":"FDA adds warning to popular GLP-1s for rare eye risk","url":"https://www.northcentralpa.com/life/fda-adds-warning-to-popular-glp-1s-for-rare-eye-risk/article_47fe47ba-fbd7-4440-b05b-0b39eda94c80.html","published":"2026-11-10T21:00:00Z","seen":"2026-11-11T01:45:19Z","lang":"en","source":{"id":"northcentralpa.com","name":"northcentralpa.com","domain":"northcentralpa.com"},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["NCPA Staff"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6700000166893005,"sentiment":"negative","tone":-0.49000000953674316,"political":0.10000000149011612},{"id":"n_kn6e3oswmddvlv6j3ioq","seq":9633119,"kind":"article","title":"FDA requires eye risk warning on Ozempic and other GLP-1s","url":"https://www.inquisitr.com/fda-glp-1-naion-warning","published":"2026-11-10T20:47:00Z","seen":"2026-11-10T22:44:19Z","lang":"en","source":{"id":"inquisitr.com","name":"inquisitr.com","domain":"inquisitr.com","outlet":{"wikidata":"Q22080989","name":"The Inquisitr","type":"website","designations":["news website"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7400000095367432,"sentiment":"negative","tone":-0.6700000166893005,"political":0.11999999731779099},{"id":"n_vbcpiexxmp3ryg2vub7a","seq":9625325,"kind":"article","title":"FDA warns of rare eye condition causing blindness from GLP-1 weight loss medications","url":"https://www.theguardian.com/us-news/2026/nov/10/fda-glp-1-weight-loss-blindness-risk","published":"2026-11-10T20:45:00Z","seen":"2026-11-10T22:22:07Z","lang":"en","country":"GB","source":{"id":"theguardian.com","name":"theguardian.com","domain":"theguardian.com","outlet":{"wikidata":"Q11148","name":"The Guardian","type":"newspaper","country":"GB","designations":["daily newspaper","newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Maya Yang"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8399999737739563,"sentiment":"negative","tone":-0.6499999761581421,"political":0.05999999865889549},{"id":"n_pfhtzmqszxzevaqhukwa","seq":9594229,"kind":"article","title":"FDA Mandates Label Updates for GLP-1 Receptor Agonists Over Eye Risk","url":"https://sleepreviewmag.com/practice-management/laws-regulations/fda/fda-mandates-label-updates-glp-1-receptor-agonists-eye-risk","published":"2026-11-10T20:15:00Z","seen":"2026-11-10T20:33:31Z","lang":"en","source":{"id":"sleepreviewmag.com","name":"sleepreviewmag.com","domain":"sleepreviewmag.com"},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["SR Edit Staff"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6299999952316284,"sentiment":"neutral","tone":-0.699999988079071,"political":0.11999999731779099},{"id":"n_egobogvepmkv63x3xelq","seq":9649600,"kind":"article","title":"FDA Orders GLP-1 Label Warnings Over Potential Vision Loss Risk","url":"https://www.klif.com/2026/11/10/fda-orders-glp-1-label-warnings-over-potential-vision-loss-risk","published":"2026-11-10T20:05:00Z","seen":"2026-11-10T23:34:41Z","lang":"en","country":"US","source":{"id":"klif.com","name":"klif.com","domain":"klif.com","outlet":{"wikidata":"Q6332720","name":"KLIF","type":"broadcaster","country":"US","designations":["radio station"]}},"via":"gdelt-gkg-english","topics":["economy","science","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.5899999737739563,"sentiment":"negative","tone":-0.6200000047683716,"political":0.09000000357627869},{"id":"n_z7snfyzba6nzd2k2p5nq","seq":9660478,"kind":"article","title":"FDA Orders GLP-1 Label Warnings Over Potential Vision Loss Risk","url":"https://www.wbap.com/2026/11/10/fda-orders-glp-1-label-warnings-over-potential-vision-loss-risk","published":"2026-11-10T20:05:00Z","seen":"2026-11-11T00:42:00Z","lang":"en","country":"US","source":{"id":"wbap.com","name":"wbap.com","domain":"wbap.com","outlet":{"wikidata":"Q6332718","name":"KLIF-FM","type":"broadcaster","country":"US","designations":["radio station"]}},"via":"gdelt-gkg-english","topics":["economy","science","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.5899999737739563,"sentiment":"negative","tone":-0.6200000047683716,"political":0.09000000357627869},{"id":"n_mr73fqo77simzlgscizq","seq":9586817,"kind":"article","title":"FDA adds rare vision-loss warning to popular GLP-1 drugs","url":"https://www.theintelligencer.net/news/top-headlines/2026/11/fda-adds-rare-vision-loss-warning-to-popular-glp-1-drugs","published":"2026-11-10T19:45:00Z","seen":"2026-11-10T20:14:48Z","lang":"en","country":"US","source":{"id":"theintelligencer.net","name":"theintelligencer.net","domain":"theintelligencer.net","outlet":{"wikidata":"Q7742245","name":"The Intelligencer & Wheeling News Register","type":"newspaper","country":"US","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7900000214576721,"sentiment":"negative","tone":-0.7400000095367432,"political":0.07000000029802322},{"id":"n_cn2viri4zbamhxtb44yq","seq":9562012,"kind":"article","title":"US FDA adds rare vision-loss warning to popular GLP-1 drugs","url":"https://economictimes.indiatimes.com/news/international/world-news/us-fda-adds-rare-vision-loss-warning-to-popular-glp-1-drugs/articleshow/135717071.cms","published":"2026-11-10T18:45:00Z","seen":"2026-11-10T18:58:29Z","lang":"en","country":"IN","source":{"id":"indiatimes.com","name":"indiatimes.com","domain":"indiatimes.com","outlet":{"wikidata":"Q113974698","name":"Indiatimes","type":"other","country":"IN","designations":["news media"]}},"via":"gdelt-gkg-english","topics":["economy","politics","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7900000214576721,"sentiment":"negative","tone":-0.7300000190734863,"political":0.07999999821186066},{"id":"n_qcfy2zks36v6aghclola","seq":9562220,"kind":"article","title":"FDA to require vision loss warning on GLP-1 drug labels - National","url":"https://globalnews.ca/news/12144337/glp1-vision-loss-warning-fda","published":"2026-11-10T18:45:00Z","seen":"2026-11-10T18:58:29Z","lang":"en","country":"CA","source":{"id":"globalnews.ca","name":"globalnews.ca","domain":"globalnews.ca","outlet":{"wikidata":"Q5570514","name":"Global News","type":"broadcaster","country":"CA","designations":["business","television channel"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Name"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6000000238418579,"sentiment":"neutral","tone":-0.7200000286102295,"political":0.27000001072883606},{"id":"n_rolbgoqxhxbjxfgaqosq","seq":9603840,"kind":"article","title":"Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness","url":"https://www.bbc.co.uk/news/articles/crwydyde0lp3o","summary":"The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.","published":"2026-11-10T18:43:04Z","seen":"2026-11-10T21:10:50Z","lang":"en","country":"GB","source":{"id":"bbc-news","name":"BBC News","domain":"bbc.co.uk","outlet":{"wikidata":"Q9531","name":"British Broadcasting Corporation","type":"public_broadcaster","country":"GB","designations":["online newspaper without paywall","public broadcaster"]}},"via":"bbc-news","entities":[{"id":"Q424611","name":"glucagon-like peptide-1","type":"other"}],"image":"https://ichef.bbci.co.uk/ace/standard/240/cpsprodpb/35c3/live/a6b43310-dd22-11f1-ab46-9fae224bbf6f.jpg","mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6800000071525574,"sentiment":"negative","tone":-0.47999998927116394,"political":0.05000000074505806},{"id":"n_ef2d3uvexdjxtjo2j5oa","seq":9571414,"kind":"article","title":"FDA adds rare vision-loss warning to popular GLP-1 drugs","url":"https://krcgtv.com/news/nation-world/fda-adds-rare-vision-loss-warning-to-popular-glp-1-drugs-11-10-2026","published":"2026-11-10T18:24:00Z","seen":"2026-11-10T19:28:52Z","lang":"en","country":"US","source":{"id":"krcgtv.com","name":"krcgtv.com","domain":"krcgtv.com","outlet":{"wikidata":"Q6336552","name":"KRCG","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7900000214576721,"sentiment":"negative","tone":-0.7400000095367432,"political":0.07000000029802322},{"id":"n_agofuzk4hkxgdyqmk3pa","seq":9634969,"kind":"article","title":"FDA adds rare vision-loss warning to popular GLP-1 drugs","url":"https://www.miamitimesonline.com/lifestyles/health_wellness/fda-adds-rare-vision-loss-warning-to-popular-glp-1-drugs/article_cedda005-c46e-444b-8243-b6e3fcdc7a9b.html","published":"2026-11-10T18:20:00Z","seen":"2026-11-10T22:47:19Z","lang":"en","country":"US","source":{"id":"miamitimesonline.com","name":"miamitimesonline.com","domain":"miamitimesonline.com","outlet":{"wikidata":"Q25025417","name":"The Miami Times","type":"newspaper","country":"US","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Matthew Perrone","The Associated Press"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7900000214576721,"sentiment":"negative","tone":-0.7400000095367432,"political":0.07000000029802322},{"id":"n_4zu4pmbnzrt2o6azjzaa","seq":9586518,"kind":"article","title":"Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness","url":"https://www.bbc.com/news/articles/crwydyde0lp3o","published":"2026-11-10T18:16:00Z","seen":"2026-11-10T20:14:48Z","lang":"en","country":"GB","source":{"id":"bbc.com","name":"bbc.com","domain":"bbc.com","outlet":{"wikidata":"Q9531","name":"British Broadcasting Corporation","type":"public_broadcaster","country":"GB","designations":["online newspaper without paywall","public broadcaster"]}},"via":"gdelt-gkg-english","topics":["health","economy"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6800000071525574,"sentiment":"negative","tone":-0.23999999463558197,"political":0.05000000074505806},{"id":"n_3d36kpn55f7vnlsjakoa","seq":9558454,"kind":"article","title":"FDA orders new warning on GLP-1 drugs over potential risk of blindness","url":"https://www.thenationalnews.com/future/science/2026/11/10/do-glps1s-cause-blindness","published":"2026-11-10T18:15:00Z","seen":"2026-11-10T18:50:54Z","lang":"en","country":"AE","source":{"id":"thenationalnews.com","name":"thenationalnews.com","domain":"thenationalnews.com","outlet":{"wikidata":"Q2544289","name":"The National","type":"newspaper","country":"AE","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Cody Combs"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6800000071525574,"sentiment":"negative","tone":-0.7400000095367432,"political":0.20000000298023224},{"id":"n_n3w226ahkr7dz5sdjsza","seq":9581083,"kind":"article","title":"FDA requires safety label changes for GLP-1s over risk for eye condition","url":"https://www.krqe.com/health/fda-requires-safety-label-changes-for-glp-1s-over-risk-for-eye-condition","summary":"NAION is often called an “eye stroke” because it occurs when blood flow to the optic nerve is reduced.","published":"2026-11-10T17:56:03Z","seen":"2026-11-10T20:02:59Z","lang":"en","country":"US","source":{"id":"kite-krqe-com-a20e88","name":"krqe.com","domain":"krqe.com","outlet":{"wikidata":"Q109973289","name":"KBIM-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"kite-krqe-com-a20e88","topics":["new-mexico","health news","latest news","national","top stories"],"authors":["Zach Kaplan"],"image":"https://www.krqe.com/wp-content/uploads/sites/12/2026/11/GettyImages-2279484867_693208-e1783009938301_65d91c.jpg?w=900","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.5600000023841858,"sentiment":"negative","tone":-0.49000000953674316,"political":0.12999999523162842},{"id":"n_wjqrv7dpqchuy6q7n5iq","seq":9588897,"kind":"article","title":"FDA to add vision-loss warning to GLP-1 drugs","url":"https://kyma.com/news/national-world/2026/11/10/fda-to-add-vision-loss-warning-to-glp-1-drugs","published":"2026-11-10T17:43:00Z","seen":"2026-11-10T20:19:29Z","lang":"en","country":"US","source":{"id":"kyma.com","name":"kyma.com","domain":"kyma.com","outlet":{"wikidata":"Q6341907","name":"KYMA-DT","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","science","health","education"],"authors":["CBS News"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.699999988079071,"sentiment":"negative","tone":-0.6100000143051147,"political":0.20999999344348907},{"id":"n_epxedqmney23apwbjc7a","seq":9531826,"kind":"article","title":"FDA adds rare vision-loss warning to popular GLP-1 drugs","url":"https://www.ksla.com/2026/11/09/fda-adds-rare-vision-loss-warning-popular-glp-1-drugs","published":"2026-11-10T17:30:00Z","seen":"2026-11-10T17:33:26Z","lang":"en","country":"US","source":{"id":"ksla.com","name":"ksla.com","domain":"ksla.com","outlet":{"wikidata":"Q6337868","name":"KSLA","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q424611","name":"glucagon-like peptide-1","type":"other"}],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7900000214576721,"sentiment":"negative","tone":-0.6499999761581421,"political":0.07000000029802322},{"id":"n_ayim2ogby5gmmtshi4wq","seq":9637789,"kind":"article","title":"FDA advierte sobre pérdida de visión posiblemente causada por medicamentos GLP-1","url":"https://laopinion.com/2026/11/10/fda-advierte-sobre-perdida-de-vision-posiblemente-causada-por-medicamentos-glp-1","published":"2026-11-10T17:01:00Z","seen":"2026-11-10T22:49:54Z","lang":"es","country":"US","source":{"id":"laopinion.com","name":"laopinion.com","domain":"laopinion.com","outlet":{"wikidata":"Q666651","name":"La Opinión","type":"newspaper","country":"US","designations":["newspaper"]}},"via":"gdelt-gkg-translingual","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.699999988079071,"sentiment":"negative","tone":-0.8199999928474426,"political":0.10000000149011612},{"id":"n_hn6cpintxlugd3rpchtq","seq":9917674,"kind":"article","title":"FDA warns GLP-1s could increase risk of vision loss","url":"https://www.wbur.org/hereandnow/2026/11/10/glp1-drugs-eye-condition","published":"2026-11-10T17:01:00Z","seen":"2026-11-11T15:59:34Z","lang":"en","country":"US","source":{"id":"wbur.org","name":"wbur.org","domain":"wbur.org","outlet":{"wikidata":"Q7947483","name":"WBUR-FM","type":"news_agency","country":"US","designations":["news agency","radio station"]}},"via":"gdelt-gkg-english","topics":["economy"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8199999928474426,"sentiment":"negative","tone":-0.8700000047683716,"political":0.11999999731779099},{"id":"n_cvtjcnanlhe2nrqfciwa","seq":9528132,"kind":"article","title":"FDA Adds Sudden Blindness Warning For GLP-1 Users | KISS 98.3 Winchester","url":"https://kiss983.iheart.com/content/2026-11-10-fda-adds-sudden-blindness-warning-for-glp-1-users","published":"2026-11-10T17:00:00Z","seen":"2026-11-10T17:24:12Z","lang":"en","country":"CA","source":{"id":"iheart.com","name":"iheart.com","domain":"iheart.com","outlet":{"wikidata":"Q793699","name":"iHeartRadio","type":"broadcaster","country":"CA","designations":["dot-com company","internet radio","podcast directory"]}},"via":"gdelt-gkg-english","topics":["economy","science"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.5099999904632568,"category2":"science-technology","sentiment":"negative","tone":-0.7599999904632568,"political":0.07999999821186066},{"id":"n_lnjakkuedijs5ahtso5q","seq":9598178,"kind":"article","title":"GLP-1 drugs get FDA warning of rare vision-loss side effect","url":"https://www.cbsnews.com/chicago/video/glp-1-drugs-get-fda-warning-of-rare-vision-loss-side-effect","summary":"GLP-1s, including Ozempic and Wegovy, will carry a new warning about a possible rare side effect that can sometimes lead to permanent vision loss, U.S. health regulators announced Monday.","published":"2026-11-10T16:36:00Z","seen":"2026-11-10T20:48:46Z","lang":"en","country":"US","source":{"id":"kite-cbsnews-com-6d98b8","name":"cbsnews.com","domain":"cbsnews.com","outlet":{"wikidata":"Q861764","name":"Q861764","type":"broadcaster","country":"US","designations":["specialty channel","television production company"]}},"via":"kite-cbsnews-com-6d98b8","topics":["chicago","cbs 2 news morning","syndication","news","spoken word wbbmtv","local news"],"authors":["CBS Chicago"],"image":"https://assets2.cbsnewsstatic.com/hub/i/r/2026/11/10/08e7c83c-ec35-4f1f-965c-ec1d61267d87/thumbnail/1024x576/3d83b568ad5796febca0a16954329268/2d8ff9b237b46d1987ec8dc6fd071c72-0-1794328608814.jpg","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7699999809265137,"sentiment":"negative","tone":-0.7599999904632568,"political":0.14000000059604645},{"id":"n_msvzqcduo5euecj5wpaa","seq":9606697,"kind":"article","title":"FDA adds rare vision-loss warning to popular GLP-1 drugs","url":"https://www.fox21news.com/health/ap-health/ap-fda-adds-rare-vision-loss-warning-to-popular-glp-1-drugs","summary":"WASHINGTON (AP) — Popular weight loss drugs including Ozempic and Wegovy will carry a new warning about a possible rare side effect that can sometimes lead to permanent vision loss, U.S. health regulators announced Monday. The Food and Drug Administration said the risk will be added to the labeling of all GLP-1 drugs, the blockbuster [...]","published":"2026-11-10T16:32:31Z","seen":"2026-11-10T21:20:51Z","lang":"en","country":"US","source":{"id":"kite-fox21news-com-4e422d","name":"fox21news.com","domain":"fox21news.com","outlet":{"wikidata":"Q6341522","name":"KXRM-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"kite-fox21news-com-4e422d","topics":["colorado","ap health","national","news","top stories"],"authors":["MATTHEW PERRONE, Associated Press"],"image":"https://www.fox21news.com/wp-content/uploads/sites/37/2026/11/6af3484d497082.74496707.jpeg?w=900","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7900000214576721,"sentiment":"negative","tone":-0.47999998927116394,"political":0.07000000029802322},{"id":"n_ezlgqofu7akyk5m4s6eq","seq":9530606,"kind":"article","title":"FDA adds rare vision-loss warning to popular GLP-1 drugs","url":"https://wsvn.com/news/us-world/fda-ozempic-wegovy-vision-warning","summary":"WASHINGTON (AP) — Popular weight loss drugs including Ozempic and Wegovy will carry a new warning about a possible rare side effect that can sometimes...","published":"2026-11-10T16:20:33Z","seen":"2026-11-10T17:37:16Z","lang":"en","country":"US","source":{"id":"kite-wsvn-com-bfe84d","name":"wsvn.com","domain":"wsvn.com","outlet":{"wikidata":"Q7956000","name":"WSVN","type":"broadcaster","country":"US","designations":["television station"]}},"via":"kite-wsvn-com-bfe84d","topics":["florida","us & world","video"],"authors":["Associated Press"],"image":"https://wsvn.com/wp-content/uploads/sites/2/2026/01/010825-glp1-drugs-review.jpg?quality=60&strip=color","mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7900000214576721,"sentiment":"negative","tone":-0.47999998927116394,"political":0.07000000029802322},{"id":"n_tbiseue6hwg33kiw7i2a","seq":9518353,"kind":"article","title":"FDA requires safety label changes for GLP-1s over risk for eye condition","url":"https://www.abc4.com/news/national/fda-safety-label-changes-for-glp-1s-eye-condition","summary":"NAION is often called an “eye stroke” because it occurs when blood flow to the optic nerve is reduced.","published":"2026-11-10T16:01:17Z","seen":"2026-11-10T16:55:28Z","lang":"en","country":"US","source":{"id":"kite-abc4-com-193bb1","name":"abc4.com","domain":"abc4.com","outlet":{"wikidata":"Q6339292","name":"KTVX","type":"broadcaster","country":"US","designations":["television station"]}},"via":"kite-abc4-com-193bb1","topics":["utah","national","top stories"],"authors":["Zach Kaplan"],"image":"https://www.abc4.com/wp-content/uploads/sites/4/2026/11/GettyImages-2279484867_693208-e1783009938301_65d91c.jpg?w=900","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.5600000023841858,"sentiment":"negative","tone":-0.49000000953674316,"political":0.12999999523162842},{"id":"n_2r5tzqq2qks3sxp7vs6q","seq":9520734,"kind":"article","title":"FDA Adds Sudden Blindness Warning For GLP-1 Users | Shenandoah Country Q102","url":"https://shenandoahcountryq102.iheart.com/content/2026-11-10-fda-adds-sudden-blindness-warning-for-glp-1-users","published":"2026-11-10T16:00:00Z","seen":"2026-11-10T16:58:02Z","lang":"en","country":"CA","source":{"id":"iheart.com","name":"iheart.com","domain":"iheart.com","outlet":{"wikidata":"Q793699","name":"iHeartRadio","type":"broadcaster","country":"CA","designations":["dot-com company","internet radio","podcast directory"]}},"via":"gdelt-gkg-english","topics":["economy","science"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.5,"sentiment":"negative","tone":-0.7799999713897705,"political":0.07999999821186066},{"id":"n_sdun3kjwjrqt5v7g2moa","seq":9521275,"kind":"article","title":"FDA Adds Sudden Blindness Warning For GLP-1 Users | Classic Country 95.7","url":"https://classiccountry957.iheart.com/content/2026-11-10-fda-adds-sudden-blindness-warning-for-glp-1-users","published":"2026-11-10T16:00:00Z","seen":"2026-11-10T16:58:02Z","lang":"en","country":"CA","source":{"id":"iheart.com","name":"iheart.com","domain":"iheart.com","outlet":{"wikidata":"Q793699","name":"iHeartRadio","type":"broadcaster","country":"CA","designations":["dot-com company","internet radio","podcast directory"]}},"via":"gdelt-gkg-english","topics":["economy","science"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.5,"sentiment":"negative","tone":-0.7599999904632568,"political":0.07000000029802322},{"id":"n_r4i4zrmt3b6admgg3vzq","seq":9521567,"kind":"article","title":"FDA Adds Sudden Blindness Warning For GLP-1 Users","url":"https://993thefox.iheart.com/content/2026-11-10-fda-adds-sudden-blindness-warning-for-glp-1-users","published":"2026-11-10T16:00:00Z","seen":"2026-11-10T16:58:02Z","lang":"en","country":"CA","source":{"id":"iheart.com","name":"iheart.com","domain":"iheart.com","outlet":{"wikidata":"Q793699","name":"iHeartRadio","type":"broadcaster","country":"CA","designations":["dot-com company","internet radio","podcast directory"]}},"via":"gdelt-gkg-english","topics":["economy","science"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.5600000023841858,"category2":"science-technology","sentiment":"negative","tone":-0.8299999833106995,"political":0.05999999865889549},{"id":"n_3w5tbyl6z54ob4whygqa","seq":9590727,"kind":"article","title":"FDA ordena incluir nuevas advertencias sobre riesgos oculares en fármacos GLP-1","url":"https://forbes.com.mx/fda-ordena-incluir-nuevas-advertencias-sobre-riesgos-oculares-en-farmacos-glp-1","published":"2026-11-10T15:41:00Z","seen":"2026-11-10T20:24:32Z","lang":"es","country":"MX","source":{"id":"forbes.com.mx","name":"forbes.com.mx","domain":"forbes.com.mx"},"via":"gdelt-gkg-translingual","topics":["economy","health"],"authors":["Forbes M&#xE9","xico Staff"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7900000214576721,"sentiment":"neutral","tone":-0.4699999988079071,"political":0.17000000178813934},{"id":"n_duzme2yo2yz54wzuhn2a","seq":9515038,"kind":"article","title":"FDA adds rare blindness warning to popular GLP-1 drugs","url":"https://www.independent.co.uk/bulletin/news/glp-blindness-ozempic-zepbound-mounjaro-b3082540.html","published":"2026-11-10T15:22:53Z","seen":"2026-11-10T16:47:12Z","lang":"en","country":"GB","source":{"id":"kite-independent-co-uk-2d4cc8","name":"independent.co.uk","domain":"independent.co.uk","outlet":{"wikidata":"Q11149","name":"The Independent","type":"newspaper","country":"GB","designations":["daily newspaper","online newspaper"]}},"via":"kite-independent-co-uk-2d4cc8","topics":["news","bulletin"],"authors":["Julia Musto"],"image":"https://static.independent.co.uk/2026/08/03/14/46/GettyImages-2280584455-(1).jpg?auto=webp&trim=0%2C0%2C0%2C0&width=1200","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7400000095367432,"sentiment":"negative","tone":-0.5,"political":0.07999999821186066},{"id":"n_tvqtdrubd36hrfl43fia","seq":9560217,"kind":"article","title":"GLP-1 drugs will now have warning label about potential increased risk of blindness","url":"https://www.wsbtv.com/news/local/glp-1-drugs-will-now-have-warning-label-about-potential-increased-risk-blindness/L5NPGR4WQNEEDEK5MXJUVZMMDA","published":"2026-11-10T15:06:00Z","seen":"2026-11-10T18:54:27Z","lang":"en","country":"US","source":{"id":"wsbtv.com","name":"wsbtv.com","domain":"wsbtv.com","outlet":{"wikidata":"Q7955494","name":"WSB-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.800000011920929,"sentiment":"negative","tone":-0.6600000262260437,"political":0.14000000059604645},{"id":"n_lokhh7uzzwxwb6qqmrrq","seq":9491313,"kind":"article","title":"FDA requires safety label changes for GLP-1s over risk for eye condition","url":"https://myfox8.com/news/fda-requires-safety-label-changes-for-glp-1s-over-risk-for-eye-condition","summary":"NAION is often called an “eye stroke” because it occurs when blood flow to the optic nerve is reduced.","published":"2026-11-10T14:59:25Z","seen":"2026-11-10T15:41:31Z","lang":"en","country":"US","source":{"id":"kite-myfox8-com-c5c85b","name":"myfox8.com","domain":"myfox8.com","outlet":{"wikidata":"Q7949771","name":"WGHP","type":"broadcaster","country":"US","designations":["television station"]}},"via":"kite-myfox8-com-c5c85b","topics":["health news","national news","news","public safety","glp-1"],"authors":["Zach Kaplan"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"image":"https://myfox8.com/wp-content/uploads/sites/17/2026/11/GettyImages-2279484867_693208-e1783009938301_65d91c.jpg?w=900","mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.5600000023841858,"sentiment":"negative","tone":-0.49000000953674316,"political":0.12999999523162842},{"id":"n_ovhpg4kfsvtjuxxiblpa","seq":9522237,"kind":"article","title":"FDA warns of potential vision loss risk linked to popular GLP-1 drugs","url":"https://www.thenews.com.pk/latest/1423151-fda-warns-of-potential-vision-loss-risk-linked-to-popular-glp-1-drugs","published":"2026-11-10T14:52:00Z","seen":"2026-11-10T17:02:25Z","lang":"en","country":"PK","source":{"id":"thenews.com.pk","name":"thenews.com.pk","domain":"thenews.com.pk","outlet":{"wikidata":"Q835669","name":"The News International","type":"newspaper","designations":["daily newspaper"]}},"via":"gdelt-gkg-english","topics":["health","economy"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8100000023841858,"sentiment":"negative","tone":-0.6899999976158142,"political":0.10999999940395355},{"id":"n_obwaxuyygw5l2ha643fa","seq":9491113,"kind":"article","title":"FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss","url":"https://arstechnica.com/health/2026/11/glp-1-drugs-may-increase-risk-of-vision-loss-from-rare-condition-fda-warns","summary":"The risk appears small and data is mixed, but FDA wants patients to be aware.","published":"2026-11-10T14:43:49Z","seen":"2026-11-10T15:39:44Z","lang":"en","source":{"id":"kite-arstechnica-com-2ec921","name":"arstechnica.com","domain":"arstechnica.com","outlet":{"wikidata":"Q584152","name":"Ars Technica","type":"website","designations":["news website"]}},"via":"kite-arstechnica-com-2ec921","topics":["smart-home","health","eye","fda","glp-1","naion","ophthalmology"],"authors":["Beth Mole"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"image":"https://cdn.arstechnica.net/wp-content/uploads/2026/02/GettyImages-1716643505-500x500.jpg","mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7900000214576721,"sentiment":"negative","tone":-0.7099999785423279,"political":0.12999999523162842},{"id":"n_kwzduzt5uphi6k4opl3q","seq":9474790,"kind":"article","title":"STAT+: GLP-1s are given an FDA warning for rare eye condition risk","url":"https://www.statnews.com/2026/11/10/biotech-news-glp-1-given-an-fda-warning-for-rare-eye-condition-risk","summary":"The FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.”","published":"2026-11-10T14:38:29Z","seen":"2026-11-10T14:46:56Z","lang":"en","country":"US","source":{"id":"kite-statnews-com-165bdc","name":"statnews.com","domain":"statnews.com","outlet":{"wikidata":"Q28452506","name":"Stat","type":"website","designations":["business","news website","website"]}},"via":"kite-statnews-com-165bdc","topics":["healthcare","usa","biotech","business","pharma","the readout","biotechnology","clinical trials"],"authors":["Elaine Chen"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"image":"https://www.statnews.com/wp-content/uploads/2025/11/AdobeStock_1666420823-645x645.jpeg","mentions":3,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6800000071525574,"sentiment":"negative","tone":-0.49000000953674316,"political":0.12999999523162842},{"id":"n_qkyt7hkitgvc4gtz3yqa","seq":9489928,"kind":"article","title":"FDA requires safety label changes for GLP-1s over risk for eye condition","url":"https://www.mychamplainvalley.com/news/national-news/fda-requires-safety-label-changes-for-glp-1s-over-risk-for-eye-condition","summary":"NAION is often called an “eye stroke” because it occurs when blood flow to the optic nerve is reduced.","published":"2026-11-10T14:36:28Z","seen":"2026-11-10T15:30:26Z","lang":"en","country":"US","source":{"id":"kite-mychamplainvalley-com-4ff75f","name":"mychamplainvalley.com","domain":"mychamplainvalley.com","outlet":{"wikidata":"Q3564671","name":"WFFF-TV","type":"broadcaster","country":"CA","designations":["television station"]}},"via":"kite-mychamplainvalley-com-4ff75f","topics":["vermont","national news"],"authors":["Zach Kaplan"],"image":"https://www.mychamplainvalley.com/wp-content/uploads/sites/61/2026/11/GettyImages-2279484867_693208-e1783009938301_65d91c.jpg?w=900","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.5600000023841858,"sentiment":"negative","tone":-0.49000000953674316,"political":0.12999999523162842},{"id":"n_ujkrudff6pil2ebnhbzq","seq":9509693,"kind":"article","title":"FDA requires safety label changes for GLP-1s over risk for eye condition","url":"https://www.fox21news.com/news/fda-requires-safety-label-changes-for-glp-1s-over-risk-for-eye-condition","summary":"NAION is often called an “eye stroke” because it occurs when blood flow to the optic nerve is reduced.","published":"2026-11-10T14:36:21Z","seen":"2026-11-10T16:37:23Z","lang":"en","country":"US","source":{"id":"kite-fox21news-com-4e422d","name":"fox21news.com","domain":"fox21news.com","outlet":{"wikidata":"Q6341522","name":"KXRM-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"kite-fox21news-com-4e422d","topics":["colorado","national","news","top stories"],"authors":["Zach Kaplan"],"image":"https://www.fox21news.com/wp-content/uploads/sites/37/2026/11/GettyImages-2279484867_693208-e1783009938301_65d91c.jpg?w=900","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.5600000023841858,"sentiment":"negative","tone":-0.49000000953674316,"political":0.12999999523162842},{"id":"n_qouyrewfu5lya2aanrfq","seq":9476786,"kind":"article","title":"What to know about new GLP-1 warning on possible vision loss","url":"https://www.cbsnews.com/video/what-to-know-about-new-glp-1-warning-on-possible-vision-loss","summary":"Dr. Jon LaPook joins \"CBS Mornings\" to break down the facts on a new warning about GLP-1 medications causing possible vision loss.","published":"2026-11-10T14:21:12Z","seen":"2026-11-10T14:51:55Z","lang":"en","country":"US","source":{"id":"kite-cbsnews-com-062e7e","name":"cbsnews.com","domain":"cbsnews.com","outlet":{"wikidata":"Q861764","name":"Q861764","type":"broadcaster","country":"US","designations":["specialty channel","television production company"]}},"via":"kite-cbsnews-com-062e7e","topics":["colorado","new-york-city"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.5199999809265137,"sentiment":"negative","tone":-0.5699999928474426,"political":0.09000000357627869},{"id":"n_45qtcx4gdoevcliatywq","seq":9514784,"kind":"article","title":"അമിതവണ്ണം കുറയ്ക്കാനുള്ള 'ജി.എൽ.പി-1' മരുന്നുകൾ കാഴ്ചശക്തിയെ ബാധിച്ചേക്കാം; മുന്നറിയിപ്പുമായി യു.എസ്. എഫ്.ഡി.എ","url":"https://www.suprabhaatham.com/details/476134/glp-1-weight-loss-drugs-may-cause-vision-loss-warns-us-fda","published":"2026-11-10T14:13:55Z","seen":"2026-11-10T16:45:58Z","lang":"ml","country":"IN","source":{"id":"kite-suprabhaatham-com-679312","name":"suprabhaatham.com","domain":"suprabhaatham.com","outlet":{"wikidata":"Q18386493","name":"Suprabhaatham","type":"magazine","designations":["periodical"]}},"via":"kite-suprabhaatham-com-679312","topics":["kerala","latestnews","news","international","health"],"authors":["Web Desk"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8600000143051147,"sentiment":"negative","tone":-0.5600000023841858,"political":0.11999999731779099},{"id":"n_6drug4u4gipddyywuy7q","seq":9576217,"kind":"article","title":"FDA'dan GLP-1 Grubu İlaçlar İçin NAION Uyarısı: Ozempic, Wegovy ve Mounjaro Etiketlerine Görme Kaybı Riski Ekleniyor","url":"https://www.saglikaktuel.com/haber/fdadan-glp-1-grubu-ilaclar-icin-naion-uyarisi-ozempic-wegovy-ve-mounjaro-etiket-108958.htm","published":"2026-11-10T13:54:00Z","seen":"2026-11-10T19:42:59Z","lang":"tr","source":{"id":"saglikaktuel.com","name":"saglikaktuel.com","domain":"saglikaktuel.com"},"via":"gdelt-gkg-translingual","topics":["economy","health"],"authors":["Sa&#x11F","l&#x131","k Aktuel"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.5899999737739563,"sentiment":"negative","tone":-0.7599999904632568,"political":0.07999999821186066},{"id":"n_3ryjcjzggzeal5pvm4ja","seq":9478393,"kind":"article","title":"FDA requires vision loss warning on GLP-1 drug labels","url":"https://www.wbay.com/2026/11/10/fda-requires-vision-loss-warning-glp-1-drug-labels","published":"2026-11-10T13:45:00Z","seen":"2026-11-10T14:47:03Z","lang":"en","country":"US","source":{"id":"wbay.com","name":"wbay.com","domain":"wbay.com","outlet":{"wikidata":"Q7946982","name":"WBAY-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7599999904632568,"sentiment":"negative","tone":-0.7900000214576721,"political":0.09000000357627869},{"id":"n_lcbsug5fhqokts2egmhq","seq":9493197,"kind":"article","title":"Glp-1 drugs linked to vision loss, warns US FDA","url":"https://www.mathrubhumi.com/health/news/glp-1-drugs-ozempic-vision-loss-us-fda-warning-nb289p5x","published":"2026-11-10T13:45:00Z","seen":"2026-11-10T15:29:34Z","lang":"ml","country":"IN","source":{"id":"mathrubhumi.com","name":"mathrubhumi.com","domain":"mathrubhumi.com","outlet":{"wikidata":"Q734491","name":"Mathrubhumi","type":"newspaper","country":"IN","designations":["newspaper"]}},"via":"gdelt-gkg-translingual","topics":["economy","health"],"authors":["Health Desk"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6800000071525574,"sentiment":"negative","tone":-0.7099999785423279,"political":0.14000000059604645},{"id":"n_62iucrk4hsyd4tozbxlq","seq":9574951,"kind":"article","title":"GLP-1 ilaçlarının etiketlerine görme kaybı uyarısı eklenecek","url":"https://medimagazin.com.tr/ilac-sanayi/glp-1-ilaclarinin-etiketlerine-gorme-kaybi-uyarisi-eklenecek-121974","published":"2026-11-10T13:30:00Z","seen":"2026-11-10T19:33:20Z","lang":"tr","country":"TR","source":{"id":"medimagazin.com.tr","name":"medimagazin.com.tr","domain":"medimagazin.com.tr"},"via":"gdelt-gkg-translingual","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7799999713897705,"sentiment":"neutral","tone":-0.5699999928474426,"political":0.09000000357627869},{"id":"n_iuuovukppjsfmpc4gupa","seq":9493112,"kind":"article","title":"FDA'dan GLP-1 Grubu İlaçlar İçin \"Nadiri Görme Kaybı\" Uyarısı: Prospektüslere NAION Riski Eklendi","url":"https://www.saglikaktuel.com/haber/fdadan-glp-1-grubu-ilaclar-icin-nadiri-gorme-kaybi-uyarisi-prospektuslere-naion-108950.htm","published":"2026-11-10T13:29:00Z","seen":"2026-11-10T15:29:34Z","lang":"tr","source":{"id":"saglikaktuel.com","name":"saglikaktuel.com","domain":"saglikaktuel.com"},"via":"gdelt-gkg-translingual","topics":["economy","health"],"authors":["Sa&#x11F","l&#x131","k Aktuel"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.5699999928474426,"sentiment":"negative","tone":-0.800000011920929,"political":0.05000000074505806},{"id":"n_pzr5rsyg4v6ftosjixgq","seq":9560329,"kind":"article","title":"FDA Adds Rare Vision-Loss Warning to Popular GLP-1 Drugs","url":"https://www.wktv.com/news/health/fda-adds-rare-vision-loss-warning-to-popular-glp-1-drugs/article_8c335e20-e039-50bd-ae43-eea155ee8b17.html","published":"2026-11-10T12:45:00Z","seen":"2026-11-10T18:54:27Z","lang":"en","country":"US","source":{"id":"wktv.com","name":"wktv.com","domain":"wktv.com","outlet":{"wikidata":"Q7951962","name":"WKTV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","science","health"],"authors":["MATTHEW PERRONE - AP Health Writer"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.75,"sentiment":"neutral","tone":-0.6000000238418579,"political":0.07999999821186066},{"id":"n_23arvttvq2dny2pi2fva","seq":9624358,"kind":"article","title":"FDA warns GLP-1s could increase risk of vision loss","url":"https://www.wknofm.org/2026-11-10/fda-warns-glp-1s-could-increase-risk-of-vision-loss","published":"2026-11-10T12:01:00Z","seen":"2026-11-10T22:22:07Z","lang":"en","country":"US","source":{"id":"wknofm.org","name":"wknofm.org","domain":"wknofm.org","outlet":{"wikidata":"Q7951808","name":"WKNO-FM","type":"broadcaster","country":"US","designations":["radio station"]}},"via":"gdelt-gkg-english","topics":["economy"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8199999928474426,"sentiment":"negative","tone":-0.8399999737739563,"political":0.11999999731779099},{"id":"n_uqlou6haqwx4tlzfisza","seq":9630709,"kind":"article","title":"FDA warns GLP-1s could increase risk of vision loss","url":"https://www.wfae.org/health/2026-11-10/fda-warns-glp-1s-could-increase-risk-of-vision-loss","published":"2026-11-10T12:01:00Z","seen":"2026-11-10T22:37:56Z","lang":"en","country":"US","source":{"id":"wfae.org","name":"wfae.org","domain":"wfae.org","outlet":{"wikidata":"Q7949161","name":"WFAE","type":"broadcaster","country":"US","designations":["nonprofit organization","radio station"]}},"via":"gdelt-gkg-english","topics":["economy"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8199999928474426,"sentiment":"negative","tone":-0.8399999737739563,"political":0.11999999731779099},{"id":"n_464fuq3bngfut4kdmgla","seq":9465175,"kind":"article","title":"Препараты GLP-1 RA: FDA предупредило о возможном риске потери зрения","url":"https://iz.ru/2199251/fda-predupredilo-o-riske-poteri-zreniia-iz-za-preparatov-dlia-pokhudeniia-izi","published":"2026-11-10T12:00:00Z","seen":"2026-11-10T13:51:59Z","lang":"ru","country":"RU","source":{"id":"iz.ru","name":"iz.ru","domain":"iz.ru","outlet":{"wikidata":"Q753932","name":"Izvestia","type":"newspaper","country":"RU","designations":["government gazette","newspaper"]}},"via":"gdelt-gkg-translingual","topics":["health","economy"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.800000011920929,"sentiment":"negative","tone":-0.8600000143051147,"political":0.09000000357627869},{"id":"n_k4b7mwokmvc7kctmnlxa","seq":9421658,"kind":"article","title":"週纖達、猛健樂入列！美FDA要求所有GLP-1藥物加註「罕見視力受損」警示","url":"https://news.cnyes.com/news/id/6655910","summary":"FDA要求所有GLP-1受體促效劑仿單加註罕見眼疾NAION警示。 FDA合併126項試驗、13萬4,253人資料，GLP-1組NAION每10萬人年6.4例，高於對照組3.8例。 諾和諾德稱資料不足證實因果；禮來評估公告內容；花旗估新增警示對整體處方需求影響有限。","published":"2026-11-10T11:10:03Z","seen":"2026-11-10T11:28:49Z","lang":"zh","country":"TW","source":{"id":"kite-news-cnyes-com-887ba2","name":"news.cnyes.com","domain":"news.cnyes.com"},"via":"kite-news-cnyes-com-887ba2","topics":["美股雷達"],"authors":["鉅亨網編譯羅昀玫"],"image":"https://cimg.cnyes.cool/static/rss/default/m/01.jpg","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7400000095367432,"sentiment":"neutral","tone":-0.44999998807907104,"political":0.05999999865889549},{"id":"n_ve2diimos5lef3ylvnbq","seq":9442292,"kind":"article","title":"Estados Unidos exige reforzar las advertencias sobre los riesgos oculares asociados a los fármacos GLP-1","url":"https://www.redaccionmedica.com/empresas/industria-farmaceutica/20261110/estados-unidos-exige-reforzar-las-advertencias-sobre-los-riesgos-oculares-asociados-farmacos-glp-1/364651_0.html","published":"2026-11-10T11:00:00Z","seen":"2026-11-10T12:24:29Z","lang":"es","source":{"id":"redaccionmedica.com","name":"redaccionmedica.com","domain":"redaccionmedica.com"},"via":"gdelt-gkg-translingual","topics":["economy","health"],"authors":["Julia Roiz"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6800000071525574,"sentiment":"negative","tone":-0.6800000071525574,"political":0.6399999856948853},{"id":"n_bsqo53ag6as3keblqqcq","seq":9406493,"kind":"article","title":"FDA flags potential vision loss risk linked to GLP-1 drugs: What users of weight-loss medications should know","url":"https://www.livemint.com/news/us-news/fda-flags-potential-vision-loss-risk-linked-to-glp-1-drugs-what-users-of-weight-loss-medications-should-know-11794304730495.html","summary":"FDA analysis of 126 clinical trials involving 134,253 participants found higher NAION incidence among GLP-1 drug users than those taking placebos or other diabetes medications.","published":"2026-11-10T10:18:26Z","seen":"2026-11-10T10:33:02Z","lang":"en","country":"IN","source":{"id":"kite-livemint-com-6d3acc","name":"livemint.com","domain":"livemint.com","outlet":{"wikidata":"Q2271133","name":"Mint","type":"newspaper","country":"IN","designations":["business periodical","newspaper"]}},"via":"kite-livemint-com-6d3acc","image":"https://www.livemint.com/lm-img/img/2026/11/10/1600x900/logo/weight_loss_drugs_1794305757375_w56s_1794305767441_BMiU_36253b13-863d-46d9-88df-3016579c92d4_OKMf.png","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8799999952316284,"sentiment":"negative","tone":-0.5899999737739563,"political":0.05999999865889549},{"id":"n_cwdpry6um6gpzpovtjta","seq":9421572,"kind":"article","title":"FDA Warning: Rare risk linked to weight-loss drugs","url":"https://www.israelnationalnews.com/news/435954","summary":"The US Food and Drug Administration has ordered the addition of a warning about a rare eye disease that can cause sudden vision loss.","published":"2026-11-10T10:18:00Z","seen":"2026-11-10T11:30:37Z","lang":"en","country":"IL","source":{"id":"kite-israelnationalnews-com-facffb","name":"israelnationalnews.com","domain":"israelnationalnews.com","outlet":{"wikidata":"Q716861","name":"Arutz Sheva","type":"broadcaster","country":"IL","designations":["media company","online newspaper","radio station"]}},"via":"kite-israelnationalnews-com-facffb","entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"image":"https://www.israelnationalnews.com/files/pictures/0/1229697.jpg","mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8999999761581421,"sentiment":"negative","tone":-0.75,"political":0.019999999552965164},{"id":"n_frvtssi2pt7ytdydxy7a","seq":9420938,"kind":"article","title":"GLP-1類減肥藥恐致失明 美FDA要求加註警示","url":"https://www.epochtimes.com/b5/26/11/10/n14886393.htm","published":"2026-11-10T10:00:00Z","seen":"2026-11-10T11:05:36Z","lang":"zh","country":"US","source":{"id":"epochtimes.com","name":"epochtimes.com","domain":"epochtimes.com","outlet":{"wikidata":"Q584472","name":"The Epoch Times","type":"newspaper","country":"US","designations":["daily newspaper"]}},"via":"gdelt-gkg-translingual","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7099999785423279,"sentiment":"negative","tone":-0.8799999952316284,"political":0.17000000178813934},{"id":"n_xlmzsoxv32asjyvzs25q","seq":9448593,"kind":"article","title":"FDA: Νέες προειδοποιήσεις για όλα τα φάρμακα GLP-1 λόγω σπάνιας πάθησης των ματιών","url":"https://sofokleous10.gr/2026/11/10/fda-%CE%BD%CE%AD%CE%B5%CF%82-%CF%80%CF%81%CE%BF%CE%B5%CE%B9%CE%B4%CE%BF%CF%80%CE%BF%CE%B9%CE%AE%CF%83%CE%B5%CE%B9%CF%82-%CE%B3%CE%B9%CE%B1-%CF%8C%CE%BB%CE%B1-%CF%84%CE%B1-%CF%86%CE%AC%CF%81%CE%BC","published":"2026-11-10T09:58:00Z","seen":"2026-11-10T12:45:54Z","lang":"el","country":"GR","source":{"id":"sofokleous10.gr","name":"sofokleous10.gr","domain":"sofokleous10.gr"},"via":"gdelt-gkg-translingual","topics":["economy","health"],"authors":["admin"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8299999833106995,"sentiment":"negative","tone":-0.5,"political":0.05000000074505806},{"id":"n_iau3f2yqnwl6swc4dxiq","seq":9382364,"kind":"article","title":"FDA traži da GLP-1 lijekovi imaju upozorenje o mogućoj trajnoj sljepoći","title_en":"FDA requests that GLP-1 drugs have a warning about possible permanent blindness","url":"https://www.telegram.hr/pitanje-zdravlja/novosti/fda-trazi-da-glp-1-lijekovi-imaju-upozorenje-o-mogucoj-trajnoj-sljepoci","summary":"Slučajevi su zabilježeni kod svih GLP-1 proizvoda koji su trenutno na tržištu, navela je FDA","published":"2026-11-10T09:02:12Z","seen":"2026-11-10T09:17:00Z","lang":"hr","country":"HR","source":{"id":"kite-telegram-hr-7386a9","name":"telegram.hr","domain":"telegram.hr","outlet":{"wikidata":"Q25502975","name":"Telegram","type":"newspaper","country":"HR","designations":["online newspaper"]}},"via":"kite-telegram-hr-7386a9","topics":["pitanje zdravlja","novosti","glp-1","sljepoća"],"authors":["Eva Benedik"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"image":"https://www.telegram.hr/wp-content/uploads/2026/11/fda-trazi-da-glp-1-lijekovi-imaju-upozorenje-o-mogucoj-trajnoj-sljepoci-150x150.jpg","mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7200000286102295,"sentiment":"negative","tone":-0.5099999904632568,"political":0.2800000011920929},{"id":"n_zkwmlofeqap45fw4h5ia","seq":9398705,"kind":"article","title":"美药管局警示GLP-1类降糖药或增一种眼病风险 - 环球新闻","url":"http://news.fjsen.com/2026-11/10/content_32281289.htm","published":"2026-11-10T09:00:00Z","seen":"2026-11-10T10:00:29Z","lang":"zh","source":{"id":"fjsen.com","name":"fjsen.com","domain":"fjsen.com"},"via":"gdelt-gkg-translingual","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8500000238418579,"sentiment":"negative","tone":-0.7699999809265137,"political":0.07999999821186066},{"id":"n_w2fpuckqe3xwgagglvba","seq":9379675,"kind":"article","title":"FDA paralajmëron për rrezikun e rrallë të humbjes së shikimit nga barnat për diabetin dhe dobësimin","url":"https://abcnews.al/fda-paralajmeron-per-rrezikun-e-rralle-te-humbjes-se-shikimit-nga-barnat-per-diabetin-dhe-dobesimin","summary":"Administrata Amerikane e Ushqimit dhe Barnave (FDA) ka kërkuar përditësimin e informacionit të sigurisë për barnat e grupit GLP-1, të përdorura për trajtimin e diabetit të tipit 2 dhe menaxhimin e peshës, duke përfshirë një paralajmërim për rrezikun e mundshëm të një sëmundjeje të rrallë të syrit që mund të shkaktojë humbje të përhershme të [...] Read More...","published":"2026-11-10T08:31:19Z","seen":"2026-11-10T09:10:00Z","lang":"sq","country":"AL","source":{"id":"kite-abcnews-al-a90759","name":"abcnews.al","domain":"abcnews.al","outlet":{"wikidata":"Q4650196","name":"ABC News","type":"broadcaster","country":"AL","designations":["broadcaster","specialty channel"]}},"via":"kite-abcnews-al-a90759","topics":["bota","të fundit","të gjitha"],"authors":["ina kashari"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8399999737739563,"sentiment":"negative","tone":-0.6600000262260437,"political":0.10000000149011612},{"id":"n_aghwoui4rjluomktdmgq","seq":9384211,"kind":"article","title":"美药管局警示：司美格鲁肽等GLP-1类降糖药可能导致失明 _ 东方财富网","url":"https://finance.eastmoney.com/a/202611103927294139.html","published":"2026-11-10T08:15:00Z","seen":"2026-11-10T09:15:42Z","lang":"zh","country":"CN","source":{"id":"eastmoney.com","name":"eastmoney.com","domain":"eastmoney.com","outlet":{"wikidata":"Q24836492","name":"East Money Information","type":"other","country":"CN","designations":["business","public company"]}},"via":"gdelt-gkg-translingual","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6800000071525574,"sentiment":"negative","tone":-0.7599999904632568,"political":0.12999999523162842},{"id":"n_osk2ko2i4bep57pjzg7q","seq":9384940,"kind":"article","title":"ה-FDA ליצרניות תרופות ההרזיה: \"הוסיפו אזהרה מפני סיכון נדיר שפוגע בראייה\"","url":"https://www.ynet.co.il/news/article/rywpifgaml","published":"2026-11-10T08:15:00Z","seen":"2026-11-10T09:15:42Z","lang":"he","country":"IL","source":{"id":"ynet.co.il","name":"ynet.co.il","domain":"ynet.co.il","outlet":{"wikidata":"Q2738307","name":"Ynet","type":"website","country":"IL","designations":["website"]}},"via":"gdelt-gkg-translingual","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6499999761581421,"sentiment":"negative","tone":-0.8100000023841858,"political":0.10000000149011612},{"id":"n_6maknifr2mpufb565koq","seq":9415009,"kind":"article","title":"\"减肥神药\"GLP-1可能导致永久性失明，美监管部门要求礼来、诺和诺德警示风险_凤凰网","url":"https://tech.ifeng.com/c/8xwHvSIa3E4","published":"2026-11-10T07:15:00Z","seen":"2026-11-10T10:52:05Z","lang":"zh","country":"CN","source":{"id":"ifeng.com","name":"ifeng.com","domain":"ifeng.com","outlet":{"wikidata":"Q724186","name":"Phoenix Television","type":"broadcaster","country":"CN","designations":["public company","state media","state-owned enterprise","television network"]}},"via":"gdelt-gkg-translingual","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6100000143051147,"sentiment":"negative","tone":-0.8799999952316284,"political":0.10000000149011612},{"id":"n_nydqe3tx6fhec7g77yka","seq":9353148,"kind":"article","title":"FDA 警告 GLP-1 减肥药可能增加突然失明风险","url":"https://www.solidot.org/story?sid=85843","summary":"FDA 周一表示，GLP-1 药物生产商须在产品标签上增加一项可能导致突然失明的警示。被称为非动脉炎性前部缺血性视神经病变(nonarteritic anterior ischemic optic neuropathy，NAION)的眼部疾病会影响视神经——负责将信号从眼睛传输至大脑的神经。当流向视神经的血液减少或受阻时，可能导致视力突然丧失，这种损伤是永久性的，目前无已知疗法。2024 年《JAMA Ophthalmology》期刊发表了一项研究，发现使用司美格鲁肽处方药的糖尿病患者患 NAION 的可能性是未使用该药患者的四倍。FDA 随后展开了调查，在审查了递交的副作用报告和多项临床试验的数据之后，FDA 发现所有 GLP-1 药物均出现 NAION 病例的报告。FDA 科学家尚未能明确药物导致 NAION 风险增加的具体机制。NAION 的某些危险因素，与 GLP-1 药物使用者中常见的健康状况——如 2 型糖尿病、肥胖症、睡眠呼吸暂停和高血压——存在重叠。","published":"2026-11-10T06:35:14Z","seen":"2026-11-10T07:42:01Z","lang":"zh","country":"CN","source":{"id":"kite-solidot-org-076e1b","name":"solidot.org","domain":"solidot.org","outlet":{"wikidata":"Q10852616","name":"Solidot","type":"newspaper","country":"CN","designations":["online newspaper"]}},"via":"kite-solidot-org-076e1b","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.800000011920929,"sentiment":"negative","tone":-0.7900000214576721,"political":0.10999999940395355},{"id":"n_v25ouioobqbnpgn7mywq","seq":9341453,"kind":"article","title":"美药管局警示GLP-1类降糖药或增一种眼病风险-新华网","url":"https://www.news.cn/world/20261110/b396fa0b9722459a986759fd07bda6a1/c.html","published":"2026-11-10T06:00:00Z","seen":"2026-11-10T06:53:55Z","lang":"zh","country":"CN","source":{"id":"news.cn","name":"news.cn","domain":"news.cn","outlet":{"wikidata":"Q204839","name":"Xinhua News Agency","type":"news_agency","country":"CN","designations":["news agency","public institution directly owned by state council"]}},"via":"gdelt-gkg-translingual","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8700000047683716,"sentiment":"negative","tone":-0.8100000023841858,"political":0.11999999731779099},{"id":"n_rbxyrkzntdnfvzv5df5q","seq":9352574,"kind":"article","title":"FDA paralajmëron për rrezikun e rrallë të humbjes së shikimit nga barnat për diabetin dhe dobësimin","url":"https://24-ore.com/fda-paralajmeron-per-rrezikun-e-rralle-te-humbjes-se-shikimit-nga-barnat-per-diabetin-dhe-dobesimin","published":"2026-11-10T05:46:00Z","seen":"2026-11-10T07:33:04Z","lang":"sq","source":{"id":"24-ore.com","name":"24-ore.com","domain":"24-ore.com"},"via":"gdelt-gkg-translingual","topics":["health","economy"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8399999737739563,"sentiment":"negative","tone":-0.8299999833106995,"political":0.10000000149011612},{"id":"n_yfptoalzzezhdz3wkp7a","seq":9321823,"kind":"article","title":"FDA arah pengeluar ubat GLP-1 tambah amaran risiko gangguan penglihatan","url":"https://www.bharian.com.my/dunia/lain-lain/2026/11/1707330/fda-arah-pengeluar-ubat-glp-1-tambah-amaran-risiko-gangguan","summary":"LOS ANGELES: Pentadbiran Makanan dan Ubat-ubatan Amerika Syarikat (FDA) pada Isnin mengarahkan pengeluar semua ubat agonis reseptor ‘glucagon-like peptide-1’ (GLP-1) mengemas kini label keselamatan produk masing-masing, lapor Xinhua.","published":"2026-11-10T05:44:00Z","seen":"2026-11-10T05:44:00Z","lang":"en","country":"MY","source":{"id":"kite-bharian-com-my-f45d9a","name":"bharian.com.my","domain":"bharian.com.my","outlet":{"wikidata":"Q2211269","name":"Berita Harian","type":"newspaper","country":"MY","designations":["newspaper","periodical"]}},"via":"kite-bharian-com-my-f45d9a","topics":["lain-lain (dunia)"],"authors":["AGENSI"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"image":"https://assets.bharian.com.my/images/articles/BH10UBAK-O_BHfield_image_listing_featured_v2.var_1794286924.jpg","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7099999785423279,"sentiment":"negative","tone":-0.6200000047683716,"political":0.11999999731779099},{"id":"n_zzagstklblrm6sqmw3ba","seq":9338598,"kind":"article","title":"FDA adds rare vision-loss warning to popular obesity, diabetes drugs","url":"https://www.thehindu.com/sci-tech/health/fda-adds-rare-vision-loss-warning-to-popular-obesity-diabetes-drugs/article71685082.ece","summary":"The eye condition, known as non-arteritic anterior ischemic optic neuropathy, can cause significant vision loss and has been reported with all GLP-1 drugs,","published":"2026-11-10T05:42:48Z","seen":"2026-11-10T06:48:00Z","lang":"en","country":"IN","source":{"id":"kite-thehindu-com-2d40b8","name":"thehindu.com","domain":"thehindu.com","outlet":{"wikidata":"Q926175","name":"The Hindu","type":"newspaper","country":"IN","designations":["newspaper"]}},"via":"kite-thehindu-com-2d40b8","topics":["health"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"image":"https://th-i.thgim.com/public/incoming/y7okua/article71685090.ece/alternates/LANDSCAPE_1200/2026-06-08T183509Z_167987873_RC2W30AWS06S_RTRMADP_3_HEALTH-PREGNANCY-GLP1.JPG","mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8999999761581421,"sentiment":"negative","tone":-0.4399999976158142,"political":0.03999999910593033},{"id":"n_3evpexmwgbyp3nmefmea","seq":9405220,"kind":"article","title":"FDA paralajmëron për rrezikun e rrallë të humbjes së shikimit nga barnat për diabetin dhe dobësimin","url":"https://ata.gov.al/2026/11/10/fda-paralajmeron-per-rrezikun-e-rralle-te-humbjes-se-shikimit-nga-barnat-per-diabetin-dhe-dobesimin","published":"2026-11-10T05:38:00Z","seen":"2026-11-10T10:19:32Z","lang":"sq","country":"AL","source":{"id":"ata.gov.al","name":"ata.gov.al","domain":"ata.gov.al","outlet":{"wikidata":"Q4709175","name":"Albanian Telegraphic Agency","type":"news_agency","country":"AL","designations":["government agency","news agency"]}},"via":"gdelt-gkg-translingual","topics":["economy","health"],"authors":["Valbona Zhupa"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.8399999737739563,"sentiment":"negative","tone":-0.8299999833106995,"political":0.10000000149011612},{"id":"n_paldtfsudrbnbhf6uosq","seq":9340478,"kind":"article","title":"US FDA requires GLP-1 drugmakers to add warning about potential eye risk","url":"https://www.freemalaysiatoday.com/category/world/2026/11/10/us-fda-requires-glp-1-drugmakers-to-add-warning-about-potential-eye-risk","published":"2026-11-10T05:15:00Z","seen":"2026-11-10T06:50:45Z","lang":"en","country":"MY","source":{"id":"freemalaysiatoday.com","name":"freemalaysiatoday.com","domain":"freemalaysiatoday.com","outlet":{"wikidata":"Q5499915","name":"Free Malaysia Today","type":"newspaper","country":"MY","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["health","economy"],"authors":["Bernama"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.75,"sentiment":"negative","tone":-0.6600000262260437,"political":0.11999999731779099},{"id":"n_phwtat6obvggo426ozaa","seq":9303132,"kind":"article","title":"FDA orders new label warning for vision loss on GLP-1 drugs","url":"https://news.crossmap.com/2026/11/09/fda-orders-new-label-warning-for-vision-loss-on-glp-1-drugs","published":"2026-11-10T04:07:00Z","seen":"2026-11-10T04:07:00Z","lang":"en","source":{"id":"crossmap.com","name":"crossmap.com","domain":"crossmap.com"},"via":"gdelt-gkg-english","entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q424611","name":"glucagon-like peptide-1","type":"other"}],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7699999809265137,"sentiment":"neutral","tone":-0.7300000190734863,"political":0.10000000149011612},{"id":"n_jgssxnczyjsctszz2tba","seq":9315117,"kind":"article","title":"New US FDA Warning Links Rare Vision Loss To Widely Used GLP-1 Drugs","url":"https://www.ndtv.com/health/fda-adds-rare-vision-loss-warning-to-popular-glp-1-drugs-12305436","summary":"The Food and Drug Administration said the risk will be added to the labeling of all GLP-1 drugs, the blockbuster medications used to treat obesity, diabetes and several other medical conditions.","published":"2026-11-10T04:03:44Z","seen":"2026-11-10T05:13:00Z","lang":"en","country":"IN","source":{"id":"kite-feedburner-com-fcf7b7","name":"feedburner.com","domain":"feeds.feedburner.com"},"via":"kite-feedburner-com-fcf7b7","topics":["news"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.75,"sentiment":"negative","tone":-0.699999988079071,"political":0.07999999821186066},{"id":"n_afzgfbbuzsevoewzoaba","seq":9308321,"kind":"article","title":"미국 FDA, 비만약 '시력 손상' 경고 문구 의무화...마운자로·위고비 등 GLP-1 전 계열 대상","url":"https://news.jtbc.co.kr/article/NB12327335","summary":"미국 식품의약국(FDA)이 글루카곤 유사 펩티드-1(GLP-1) 계열 비만·당뇨병 치료제에 시력 상실 위험 관련 경고 문구를 추가하도록 했습니다. 최근 인기를 끌고 있는 비만치료제인 노보노디스크의 '위고비'와 '오","published":"2026-11-10T03:41:20Z","seen":"2026-11-10T04:35:00Z","lang":"ko","country":"KR","source":{"id":"kite-news-ex-jtbc-co-kr-a203a0","name":"news-ex.jtbc.co.kr","domain":"news-ex.jtbc.co.kr"},"via":"kite-news-ex-jtbc-co-kr-a203a0","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.5400000214576721,"sentiment":"negative","tone":-0.5299999713897705,"political":0.17000000178813934},{"id":"n_c4pjajdfjw42tabjuloq","seq":9300002,"kind":"community","title":"FDA Warns GLP-1s May Increase Risk of Sudden Blindness","url":"https://science.slashdot.org/story/26/11/09/231215/fda-warns-glp-1s-may-increase-risk-of-sudden-blindness","summary":"An anonymous reader quotes a report from NBC News: The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness. The condition, called nonarteritic anterior ischemic optic neuropathy, or NAION, affects the optic nerve, which carries signals from the eye to the brain. When blood flow to the nerve is reduced or blocked, it can cause sudden vision loss. The condition is permanent with no…","published":"2026-11-10T03:30:00Z","seen":"2026-11-10T03:48:00Z","lang":"en","source":{"id":"slashdot","name":"Slashdot","domain":"slashdot.org","outlet":{"wikidata":"Q59083","name":"Slashdot","type":"website","designations":["social news website","website"]}},"via":"slashdot","topics":["technology"],"authors":["BeauHD"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7300000190734863,"sentiment":"negative","tone":-0.7099999785423279,"political":0.09000000357627869},{"id":"n_6s7xtjqohfryzsro3vna","seq":9314081,"kind":"article","title":"FDA to weight-loss drug manufacturers: 'Add warning about rare risk affecting vision'","url":"https://www.ynetnews.com/article/8983nczpw","published":"2026-11-10T03:26:46Z","seen":"2026-11-10T05:03:01Z","lang":"he","country":"IL","source":{"id":"kite-ynet-co-il-27847a","name":"ynet.co.il","domain":"ynet.co.il","outlet":{"wikidata":"Q2738307","name":"Ynet","type":"website","country":"IL","designations":["website"]}},"via":"kite-ynet-co-il-27847a","authors":["author"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.800000011920929,"sentiment":"negative","tone":-0.6000000238418579,"political":0.05000000074505806},{"id":"n_gicsvf642iycw362fd4a","seq":9291581,"kind":"article","title":"FDA Now Requiring GLP-1 Makers to Warn About Rare but Severe Eye Condition","url":"https://wcbm.com/national-headline/fda-now-requiring-glp-1-makers-to-warn-about-rare-but-severe-eye-condition","published":"2026-11-10T03:00:00Z","seen":"2026-11-10T03:13:43Z","lang":"en","country":"US","source":{"id":"wcbm.com","name":"wcbm.com","domain":"wcbm.com","outlet":{"wikidata":"Q7947629","name":"WCBM","type":"broadcaster","country":"US","designations":["radio station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.5,"category2":"science-technology","sentiment":"neutral","tone":-0.550000011920929,"political":0.07000000029802322},{"id":"n_p4fjrfycqpks53af27rq","seq":9322951,"kind":"article","title":"Risque visuel des GLP-1 : la FDA impose un avertissement","url":"https://libnanews.com/risque-visuel-des-glp-1-la-fda-impose-un-avertissement","published":"2026-11-10T02:56:00Z","seen":"2026-11-10T05:39:00Z","lang":"fr","source":{"id":"libnanews.com","name":"libnanews.com","domain":"libnanews.com"},"via":"gdelt-gkg-translingual","topics":["economy","health"],"authors":["Newsdesk Libnanews"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.6899999976158142,"sentiment":"negative","tone":-0.8700000047683716,"political":0.09000000357627869},{"id":"n_kzgilp3u3af6vvd7vgia","seq":9289193,"kind":"article","title":"FDA adds warning for rare vision loss to popular GLP-1s","url":"https://www.koco.com/article/fda-glp-1-vision-loss-naion/74379027","published":"2026-11-10T02:30:00Z","seen":"2026-11-10T03:06:35Z","lang":"en","country":"US","source":{"id":"koco.com","name":"koco.com","domain":"koco.com","outlet":{"wikidata":"Q6334811","name":"KOCO-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Livia Daggett"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.75,"sentiment":"negative","tone":-0.699999988079071,"political":0.05000000074505806},{"id":"n_3xq2munjvjmkjuw6rb6q","seq":9289377,"kind":"article","title":"FDA adds warning for rare vision loss to popular GLP-1s","url":"https://www.wjcl.com/article/fda-glp-1-vision-loss-naion/74379027","published":"2026-11-10T02:30:00Z","seen":"2026-11-10T03:06:35Z","lang":"en","country":"US","source":{"id":"wjcl.com","name":"wjcl.com","domain":"wjcl.com","outlet":{"wikidata":"Q7951102","name":"WJCL","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Livia Daggett"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.75,"sentiment":"negative","tone":-0.699999988079071,"political":0.05000000074505806},{"id":"n_e5ptuhllakkr4o5sprsq","seq":9289454,"kind":"article","title":"FDA adds warning for rare vision loss to popular GLP-1s","url":"https://www.wdsu.com/article/fda-glp-1-vision-loss-naion/74379027","published":"2026-11-10T02:30:00Z","seen":"2026-11-10T03:06:35Z","lang":"en","country":"US","source":{"id":"wdsu.com","name":"wdsu.com","domain":"wdsu.com","outlet":{"wikidata":"Q7948586","name":"WDSU","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Livia Daggett"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.75,"sentiment":"negative","tone":-0.699999988079071,"political":0.05000000074505806},{"id":"n_l6brpw7otsxhwbxz3krq","seq":9288013,"kind":"article","title":"FDA adds warning for rare vision loss to popular GLP-1s","url":"https://www.kmbc.com/article/fda-glp-1-vision-loss-naion/74379027","published":"2026-11-10T02:15:00Z","seen":"2026-11-10T03:04:00Z","lang":"en","country":"US","source":{"id":"kmbc.com","name":"kmbc.com","domain":"kmbc.com","outlet":{"wikidata":"Q6657537","name":"KMBC-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Livia Daggett"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.75,"sentiment":"negative","tone":-0.699999988079071,"political":0.05000000074505806},{"id":"n_pyug7vw6ny6ultliphqq","seq":9288016,"kind":"article","title":"FDA adds warning for rare vision loss to popular GLP-1s","url":"https://www.wisn.com/article/fda-glp-1-vision-loss-naion/74379027","published":"2026-11-10T02:15:00Z","seen":"2026-11-10T03:04:00Z","lang":"en","country":"US","source":{"id":"wisn.com","name":"wisn.com","domain":"wisn.com","outlet":{"wikidata":"Q3564700","name":"WISN-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Livia Daggett"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.75,"sentiment":"negative","tone":-0.699999988079071,"political":0.05000000074505806},{"id":"n_biwhf3imiw6lqkpw7rqa","seq":9273721,"kind":"article","title":"FDA adds warning for rare vision loss to popular GLP-1s","url":"https://www.wvtm13.com/article/fda-glp-1-vision-loss-naion/74379027","published":"2026-11-10T01:35:00Z","seen":"2026-11-10T01:35:00Z","lang":"en","country":"US","source":{"id":"wvtm13.com","name":"wvtm13.com","domain":"wvtm13.com","outlet":{"wikidata":"Q7957034","name":"WVTM-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Livia Daggett"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q5572286","name":"glucagon-like peptide-1 agonist","type":"other"}],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.75,"sentiment":"negative","tone":-0.699999988079071,"political":0.05000000074505806},{"id":"n_fqfbh6vagmagmp7sx6eq","seq":9271125,"kind":"article","title":"FDA adds warning for rare vision loss to popular GLP-1s","url":"https://www.4029tv.com/article/fda-glp-1-vision-loss-naion/74379027","published":"2026-11-10T01:26:51Z","seen":"2026-11-10T01:26:51Z","lang":"en","country":"US","source":{"id":"4029tv.com","name":"4029tv.com","domain":"4029tv.com","outlet":{"wikidata":"Q6330036","name":"KHBS","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Livia Daggett"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.75,"sentiment":"negative","tone":-0.699999988079071,"political":0.05000000074505806},{"id":"n_o6nr5h7nfrlosfzfegsa","seq":9268527,"kind":"article","title":"FDA adds warning for rare vision loss to popular GLP-1s","url":"https://www.wyff4.com/article/fda-glp-1-vision-loss-naion/74379027","published":"2026-11-10T01:09:00Z","seen":"2026-11-10T01:09:00Z","lang":"en","source":{"id":"wyff4.com","name":"wyff4.com","domain":"wyff4.com"},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Livia Daggett"],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.75,"sentiment":"negative","tone":-0.699999988079071,"political":0.05000000074505806},{"id":"n_pcttmf5wqyj64ukr5ygq","seq":9268895,"kind":"article","title":"FDA adds rare vision-loss warning to popular GLP-1 drugs","url":"https://www.wral.com/news/ap/d85a5-fda-adds-rare-vision-loss-warning-to-popular-glp-1-drugs","published":"2026-11-10T01:09:00Z","seen":"2026-11-10T01:09:00Z","lang":"en","country":"US","source":{"id":"wral.com","name":"wral.com","domain":"wral.com","outlet":{"wikidata":"Q1390360","name":"WRAL-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health","science"],"authors":["MATTHEW PERRONE &#x2014","AP Health Writer"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"mentions":3,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.7900000214576721,"sentiment":"negative","tone":-0.6399999856948853,"political":0.07000000029802322},{"id":"n_pc6fenj6fyksbsointxq","seq":9267122,"kind":"article","title":"FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness","url":"https://www.nbcboston.com/news/health/fda-warning-glp-rare-eye-condition-sudden-blindness/4046477","summary":"The chairwoman of the Massachusetts Republican Party announced Monday that she won’t seek another term, a major shakeup for the party in the wake of heavy GOP losses in last week’s election . Amy Carnevale, a longtime lobbyist and state committee member, was first elected chair of the Massachusetts Republican State Committee in 2023, narrowly defeating incumbent Jim Lyons. She won reelection by a wide margin last year. “Serving as Chair for the past four years has been one…","published":"2026-11-10T01:06:03Z","seen":"2026-11-10T01:06:03Z","lang":"en","country":"US","source":{"id":"kite-nbcboston-com-3950e3","name":"nbcboston.com","domain":"nbcboston.com","outlet":{"wikidata":"Q7957979","name":"WBTS-CD","type":"broadcaster","country":"US","designations":["television station"]}},"via":"kite-nbcboston-com-3950e3","topics":["vermont","post"],"authors":["Berkeley Lovelace Jr. | NBC News"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q5572286","name":"glucagon-like peptide-1 agonist","type":"other"}],"image":"https://media.nbcboston.com/2026/11/Syringe-needle-drops-medication-beside-glp1-vial-o-2301238006-Getty.jpg?fit=5459,3071&quality=85&strip=all","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.5600000023841858,"sentiment":"negative","tone":-0.5299999713897705,"political":0.10999999940395355}]}